Doug Altman

Q: What Schools Are Affiliated With Doug Altman

Doug Altman is affiliated with the following schools: Paris Diderot University, University of Bath, University of Bristol, University of Oxford, Wake Forest University, University of Dundee, United Medical and Dental Schools of Guy's and St Thomas' Hospitals, Stanford University

Doug Altman's AcademicInfluence.com Rankings

Doug Altman

Mathematics

#217

World Rank

#486

Historical Rank

Statistics

World Rank

Historical Rank

mathematics Degrees

Doug Altman

Philosophy

#226

World Rank

#545

Historical Rank

Logic

#11

World Rank

#55

Historical Rank

philosophy Degrees

Download Badge

Mathematics
Philosophy

Why Is Doug Altman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Douglas Graham Altman FMedSci was an English statistician best known for his work on improving the reliability and reporting of medical research and for highly cited papers on statistical methodology. He was professor of statistics in medicine at the University of Oxford, founder and Director of Centre for Statistics in Medicine and Cancer Research UK Medical Statistics Group, and co-founder of the international Equator Network for health research reliability.

(See a Problem?)

Doug Altman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT (1986) (46513)
Measuring inconsistency in meta-analyses (2003) (44805)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (2010) (41666)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009) (32445)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) (24017)
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials (2011) (21564)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009) (20340)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement (2009) (19605)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (2007) (18663)
Practical statistics for medical research (1990) (18412)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009) (13688)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (2009) (11776)
Measuring agreement in method comparison studies (1999) (7906)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. (2009) (7631)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016) (7256)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2007) (7183)
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials (2010) (6599)
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. (1995) (6119)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007) (6009)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (2008) (5931)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research (2010) (5679)
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (2014) (5227)
Chapter 8: Assessing risk of bias in included studies (2008) (4657)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010) (4451)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) (4355)
Assessing Risk of Bias in Included Studies (2008) (4351)
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010) (4153)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010) (4149)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007) (4141)
Statistics notes: Cronbach's alpha (1997) (4098)
Measurement in Medicine: The Analysis of Method Comparison Studies (1983) (3893)
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001) (3830)
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010) (3790)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. (2014) (3753)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (2015) (3720)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. (2009) (3700)
SPIRIT 2013 statement: defining standard protocol items for clinical trials. (2013) (3679)
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials (2010) (3478)
Multiple significance tests: the Bonferroni method (1995) (3443)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (2009) (3428)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001) (3409)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001) (3146)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines (2010) (3133)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013) (3035)
PRISMA statement. (2011) (2896)
Chapter 9: Analysing Data and Undertaking Meta-Analyses (2008) (2885)
Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (2009) (2834)
Evaluating non-randomised intervention studies. (2003) (2633)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration (2015) (2626)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (2001) (2451)
Assessing the quality of controlled clinical trials (2001) (2372)
Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (2007) (2358)
Interaction revisited: the difference between two estimates (2003) (2349)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2003) (2329)
Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies (2007) (2298)
Comparing methods of measurement: why plotting difference against standard method is misleading (1995) (2270)
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study (2008) (2157)
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. (2008) (2118)
Reporting recommendations for tumor marker prognostic studies (REMARK). (2005) (2075)
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. (2010) (2066)
Analysing data and undertaking meta‐analyses (2019) (2045)
Systematic reviews in health care : meta-analysis in context (2008) (2009)
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies (2015) (1966)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement (2015) (1961)
Confidence intervals rather than P values: estimation rather than hypothesis testing. (1986) (1887)
Dichotomizing continuous predictors in multiple regression: a bad idea (2006) (1866)
[The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. (2007) (1810)
Consort 2010 statement: extension to cluster randomised trials (2004) (1781)
The cost of dichotomising continuous variables (2006) (1752)
Analysing controlled trials with baseline and follow up measurements (2001) (1748)
Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. (1994) (1731)
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations (2016) (1720)
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. (2004) (1706)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research † (2012) (1692)
CONSORT statement: extension to cluster randomised trials (2004) (1684)
Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta‐Analysis (2008) (1668)
Analysis of serial measurements in medical research. (1990) (1531)
Improving the reporting of pragmatic trials: an extension of the CONSORT statement (2008) (1523)
Systematic Reviews in Health Care (2001) (1506)
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. (2006) (1505)
Agreement Between Methods of Measurement with Multiple Observations Per Individual (2007) (1501)
Meta-analyses involving cross-over trials: methodological issues. (2002) (1480)
No surgical innovation without evaluation: the IDEAL recommendations (2009) (1430)
What do we mean by validating a prognostic model? (2000) (1424)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007) (1422)
Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias (2008) (1390)
Diagnostic tests 4: likelihood ratios (2004) (1338)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. (2007) (1310)
Statistics Notes: Diagnostic tests 1: sensitivity and specificity (1994) (1287)
International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project (2014) (1284)
Explanation and Elaboration (1282)
Statistics Notes: Diagnostic tests 2: predictive values (1994) (1273)
Statistics with confidence: Confidence intervals and statistical guidelines . (1990) (1272)
Applying the right statistics: analyses of measurement studies (2003) (1268)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. (2007) (1260)
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (2010) (1253)
Prognosis and prognostic research: validating a prognostic model (2009) (1228)
Developing core outcome sets for clinical trials: issues to consider (2012) (1186)
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration (2016) (1139)
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004) (1135)
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. (1994) (1100)
Statistics notes: Absence of evidence is not evidence of absence (1995) (1097)
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial (2002) (1083)
Prognosis and prognostic research: what, why, and how? (2009) (1071)
The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development (2013) (1026)
Prognosis and prognostic research: Developing a prognostic model (2009) (1017)
Missing data (2007) (1016)
Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research (2013) (990)
Measurement error. (1996) (961)
The COMET Handbook: version 1.0 (2017) (953)
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses (2003) (948)
Reducing waste from incomplete or unusable reports of biomedical research (2014) (940)
Calculating correlation coefficients with repeated observations: Part 2—correlation between subjects (1995) (929)
A catalogue of reporting guidelines for health research (2010) (924)
The odds ratio (2000) (920)
Chapter 16: Special Topics in Statistics (2008) (918)
Guidelines for Reporting Observational Studies (2007) (892)
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews (2010) (891)
Metan: Fixed- and Random-Effects Meta-Analysis (2008) (877)
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. (2006) (873)
Risk prediction models: II. External validation, model updating, and impact assessment (2012) (871)
Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials (2012) (871)
Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist (2014) (867)
Statistics Notes: Detecting skewness from summary information (1996) (865)
Guidance for Developers of Health Research Reporting Guidelines (2010) (843)
Statistics notes: Measurement error (1996) (842)
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. (2010) (830)
Systematic reviews of evaluations of prognostic variables (2001) (829)
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (2006) (818)
CONSORT 2010 statement: extension to randomised pilot and feasibility trials (2016) (813)
Prognosis and prognostic research: application and impact of prognostic models in clinical practice (2009) (812)
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. (2013) (810)
Epidemiology and Reporting Characteristics of Systematic Reviews (2007) (796)
Reporting recommendations for tumor marker prognostic studies. (2005) (787)
Statistics notes: Calculating correlation coefficients with repeated observations: Part 1—correlation within subjects (1995) (774)
A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers (2009) (767)
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. (2009) (751)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010) (739)
CARE guidelines for case reports: explanation and elaboration document. (2017) (736)
Guidelines for the design and statistical analysis of experiments using laboratory animals. (2002) (729)
Statistical guidelines for contributors to medical journals. (1983) (729)
Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries (2001) (728)
The scandal of poor medical research (1994) (721)
Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker (2012) (718)
Indirect comparisons of competing interventions. (2005) (701)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001) (694)
Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals (2009) (689)
SPIRIT 2013 Statement: defining standard protocol items for clinical trials. (2015) (688)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (2008) (688)
The logrank test (2004) (686)
The design of simulation studies in medical statistics (2006) (682)
CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. (2017) (667)
Survival Analysis Part I: Basic concepts and first analyses (2003) (664)
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. (2010) (663)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. (2015) (657)
Comparison of registered and published primary outcomes in randomized controlled trials. (2009) (652)
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. (2010) (647)
A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. (1990) (641)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement (2015) (640)
Survival probabilities (the Kaplan-Meier method) (1998) (638)
External validation of a Cox prognostic model: principles and methods (2013) (634)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement (2015) (616)
Calculating the number needed to treat for trials where the outcome is time to an event (1999) (616)
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. (2012) (614)
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. (2010) (609)
Statistics Notes: Diagnostic tests 3: receiver operating characteristic plots (1994) (605)
Statistical aspects of prognostic factor studies in oncology. (1994) (595)
International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project (2014) (589)
Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice (2002) (587)
Sparse data bias: a problem hiding in plain sight (2016) (587)
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]. (2007) (581)
Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines (2009) (581)
Better reporting of randomised controlled trials: the CONSORT statement (1996) (578)
Statistics and ethics in medical research: III How large a sample? (1980) (570)
Confidence intervals for the number needed to treat (1998) (567)
Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research (2013) (564)
Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methods (2003) (562)
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. (2012) (548)
REporting recommendations for tumour MARKer prognostic studies (REMARK) (2005) (543)
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration (2012) (536)
REporting recommendations for tumor MARKer prognostic studies (REMARK) (2005) (534)
Standard deviations and standard errors (2005) (517)
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors (2005) (514)
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research (2017) (513)
Statistics Notes: Measurement error and correlation coefficients (1996) (510)
Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. (1994) (501)
Statistics Notes: Measurement error proportional to the mean (1996) (495)
Millennials at Work: What We Know and What We Need to Do (If Anything) (2010) (491)
CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration (2008) (485)
Special Topics in Statistics (2008) (481)
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. (2008) (480)
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa (2012) (479)
Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes (2013) (477)
Randomisation and baseline comparisons in clinical trials (1990) (476)
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study (2010) (475)
Blinding in clinical trials and other studies (2000) (474)
Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets (2008) (473)
The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed (2010) (472)
STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. (2015) (467)
Reporting and Methods in Clinical Prediction Research: A Systematic Review (2012) (466)
External validation of multivariable prediction models: a systematic review of methodological conduct and reporting (2014) (465)
The CARE guidelines: consensus-based clinical case report guideline development. (2014) (464)
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis (2016) (463)
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research (2017) (462)
Epidemiology and reporting of randomised trials published in PubMed journals (2005) (457)
Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons (1995) (456)
Treatment allocation by minimisation (2005) (456)
Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study (2016) (452)
PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts (2013) (449)
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research (2004) (442)
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. (2007) (442)
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) (2011) (435)
CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. (2005) (434)
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls (2002) (424)
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. (2010) (419)
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal (2010) (417)
How to randomise (1999) (413)
Erratum to: “CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials” [J Clin Epidemiol 2010;63(8):e1–37] (2012) (412)
Commentary: Prognostic models: clinically useful or quickly forgotten? (1995) (408)
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension (2018) (408)
The CARE Guidelines: Consensus‐Based Clinical Case Reporting Guideline Development (2013) (406)
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis (2014) (399)
Statistic Notes: Regression towards the mean (1994) (395)
Sample size considerations for the external validation of a multivariable prognostic model: a resampling study (2015) (395)
Review of survival analyses published in cancer journals. (1995) (395)
Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews (2009) (389)
Statistics notes: The normal distribution (1995) (387)
Charts of fetal size: 1. Methodology (1994) (385)
Prognosis research strategy (PROGRESS) 4: Stratified medicine research (2013) (385)
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. (1985) (379)
REporting recommendations for tumour MARKer prognostic studies (REMARK) (2006) (375)
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials (2018) (372)
Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network (2010) (364)
More informative abstracts revisited. (1990) (359)
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. (1991) (353)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement (2015) (345)
Survival Analysis Part III: Multivariate data analysis – choosing a model and assessing its adequacy and fit (2003) (343)
Statistics Notes: Some examples of regression towards the mean (1994) (339)
The benefits and harms of breast cancer screening: an independent review (2013) (338)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012) (335)
Core Outcome Set–STAndards for Reporting: The COS-STAR Statement (2016) (334)
Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta‐epidemiological’ research (2002) (333)
Reliability and initial validation of the ulcerative colitis endoscopic index of severity. (2013) (332)
Basic statistical reporting for articles published in biomedical journals: the "Statistical Analyses and Methods in the Published Literature" or the SAMPL Guidelines. (2015) (331)
Treatment allocation in controlled trials: why randomise? (1999) (329)
Core Outcome Set-STAndards for Development: The COS-STAD recommendations (2017) (327)
External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges (2016) (325)
Sustaining interventions in community systems: on the relationship between researchers and communities. (1995) (324)
Bootstrap investigation of the stability of a Cox regression model. (1989) (324)
Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines (2011) (323)
PRISMA harms checklist: improving harms reporting in systematic reviews (2016) (323)
Charts of fetal size: 2. Head measurements * (1994) (314)
Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. (2016) (308)
How to obtain the P value from a confidence interval (2011) (308)
A guide to systematic review and meta-analysis of prognostic factor studies (2019) (307)
How to obtain the confidence interval from a P value (2011) (306)
Credibility of claims of subgroup effects in randomised controlled trials: systematic review (2012) (305)
Statistics notes: Transformations, means, and confidence intervals (1996) (303)
Comparing two methods of clinical measurement: a personal history. (1995) (303)
Inverse probability weighting (2016) (301)
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement (2010) (297)
Construction of age-related reference centiles using absolute residuals. (1993) (290)
The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional Study. (2014) (290)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) (2015) (289)
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement. (2010) (289)
Poor-quality medical research: what can journals do? (2002) (287)
Comparability of Randomised Groups (1985) (286)
Charts of fetal size: 3. Abdominal measurements (1994) (278)
STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. (2015) (277)
Absence of evidence is not evidence of absence. (1996) (277)
Statistics Notes: The use of transformation when comparing two means (1996) (272)
Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation (2014) (269)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration (2018) (265)
Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). (2010) (265)
Reporting of Noninferiority and Equivalence Randomized Trials (2013) (264)
Bilateral versus Single Internal‐Thoracic‐Artery Grafts at 10 Years (2019) (259)
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (2001) (258)
Design, analysis, and presentation of crossover trials (2009) (257)
Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review (2012) (256)
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study (2018) (256)
Declaración de la Iniciativa STROBE (Strengthening the Reporting of Observational studies in Epidemiology): directrices para la comunicación de estudios observacionales (2008) (256)
Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial. (2014) (255)
Statistics in medical journals: developments in the 1980s. (1991) (255)
Ghost Authorship in Industry-Initiated Randomised Trials (2007) (254)
Analysis and reporting of factorial trials: a systematic review. (2003) (253)
Adequate sample size for developing prediction models is not simply related to events per variable (2016) (251)
Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies (2016) (251)
Uses and misuses of the STROBE statement: bibliographic study (2011) (249)
Sample size for binary logistic prediction models: Beyond events per variable criteria (2018) (246)
Comparison of protocols and registry entries to published reports for randomised controlled trials. (2011) (245)
No rationale for 1 variable per 10 events criterion for binary logistic regression analysis (2016) (245)
Distinguishing Case Series From Cohort Studies (2012) (245)
IDEAL framework for surgical innovation 1: the idea and development stages (2013) (242)
The Landscape and Lexicon of Blinding in Randomized Trials (2002) (241)
Effect of Bilateral Internal Mammary Artery Grafts on Long-Term Survival: A Meta-Analysis Approach (2014) (241)
Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis (2012) (240)
Development and validation of a prediction model with missing predictor data: a practical approach. (2010) (239)
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors' (2008) (237)
Issues in data monitoring and interim analysis of trials. (2005) (237)
Charts of fetal size: 4. Femur length (1994) (237)
Adolescent sexual victimization, use of alcohol and other substances, and other health risk behaviors. (2004) (235)
A proposed charter for clinical trial data monitoring committees: helping them to do their job well (2005) (234)
Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) (2015) (232)
CONSORT 2010 statement: extension to randomised crossover trials (2019) (231)
Guidelines for the Content of Statistical Analysis Plans in Clinical Trials (2017) (231)
USING CONFIDENCE INTERVALS (1987) (231)
Statistics Notes: Units of analysis (1997) (230)
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research (2010) (229)
Driving up the Quality and Relevance of Research Through the Use of Agreed Core Outcomes (2012) (229)
Statistics Notes: Transforming data (1996) (229)
Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review (2014) (228)
CONSORT for reporting randomised trials in journal and conference abstracts (2008) (226)
AKI and Long-Term Risk for Cardiovascular Events and Mortality. (2017) (224)
The efficacy of problem-solving treatments after deliberate self-harm: meta-analysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems (2001) (223)
Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2 (2012) (222)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2009) (222)
Agreed statistics: measurement method comparison. (2012) (221)
Down with odds ratios! (1996) (219)
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines (2004) (218)
Postnatal growth standards for preterm infants: the Preterm Postnatal Follow-up Study of the INTERGROWTH-21(st) Project. (2015) (217)
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma. (1988) (217)
The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study (2009) (216)
COMMON DNA POLYMORPHISM WITHIN CODING SEQUENCE OF APOLIPOPROTEIN B GENE ASSOCIATED WITH ALTERED LIPID LEVELS (1986) (215)
Statistics in medical journals. (1982) (215)
An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study (2010) (213)
Concealing treatment allocation in randomised trials (2001) (213)
International estimated fetal weight standards of the INTERGROWTH‐21st Project (2017) (211)
International estimated fetal weight standards of the INTERGROWTH‐21st Project (2017) (211)
Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study (2010) (210)
Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. (1995) (210)
Developing a prognostic model in the presence of missing data: an ovarian cancer case study. (2003) (209)
Quantification of the completeness of follow-up (2002) (209)
COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) (208)
metan-an alternative meta-analysis command (1999) (207)
Population attributable fraction (2018) (206)
SPIRIT 2013: new guidance for content of clinical trial protocols (2013) (206)
Interpreting diagnostic accuracy studies for patient care (2012) (204)
Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial (2011) (204)
Taking healthcare interventions from trial to practice (2010) (199)
Guidelines for Reporting Health Research: The EQUATOR Network's Survey of Guideline Authors (2008) (198)
The CARE guidelines: consensus-based clinical case reporting guideline development (2013) (197)
A prognostic model for ovarian cancer (2001) (195)
Analysis by Categorizing or Dichotomizing Continuous Variables Is Inadvisable: An Example from the Natural History of Unruptured Aneurysms (2011) (195)
Statistics in medical journals: some recent trends. (2000) (194)
Is Office-Based Counseling About Media Use, Timeouts, and Firearm Storage Effective? Results From a Cluster-Randomized, Controlled Trial (2008) (194)
Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists (2011) (193)
EQUATOR: reporting guidelines for health research (2008) (192)
Reporting methods in studies developing prognostic models in cancer: a review (2010) (192)
Validating scales and indexes (2002) (190)
REporting recommendations for tumour MARKer prognostic studies (REMARK). (2005) (189)
New charts for ultrasound dating of pregnancy (1997) (189)
The CARE guidelines: consensus-based clinical case reporting guideline development (2013) (186)
Association between gas cooking and respiratory disease in children. (1977) (186)
Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review (2014) (185)
Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice (2012) (184)
Charts of Fetal Size (1994) (183)
Statistics Notes: Correlation, regression, and repeated data (1994) (182)
Assessing the Quality of Randomised Controlled Trials (2008) (182)
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study (2011) (181)
Meta‐analysis combining parallel and cross‐over clinical trials. I: Continuous outcomes (2002) (180)
Survival Analysis Part IV: Further concepts and methods in survival analysis (2003) (178)
Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols (2008) (178)
An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study (2009) (175)
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure. (2017) (174)
REGRESSION ANALYSIS (1986) (173)
Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study (2005) (172)
Reporting performance of prognostic models in cancer: a review (2010) (172)
Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors (2005) (171)
Outcome selection bias in meta-analysis (2005) (171)
Statistics Notes: Interaction 2: compare effect sizes not P values (1996) (169)
Systematic review adherence to methodological or reporting quality (2017) (169)
Tobacco promotion and susceptibility to tobacco use among adolescents aged 12 through 17 years in a nationally representative sample. (1996) (168)
International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown–rump length in the first trimester of pregnancy (2014) (168)
Considering bias and conflicts of interest among the included studies (2019) (167)
Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. (1994) (167)
The relation between treatment benefit and underlying risk in meta-analysis (1996) (167)
The science of clinical practice: disease diagnosis or patient prognosis? Evidence about “what is likely to happen” should shape clinical practice (2015) (165)
Improving Doctors' understanding of statistics (1991) (164)
Effects of a drug overdose in a television drama on presentations to hospital for self poisoning: time series and questionnaire study (1999) (163)
Statistics Notes: Measurement error (1996) (163)
Ten steps towards improving prognosis research (2009) (162)
Odds ratios should be avoided when events are common (1998) (162)
Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews (2014) (161)
Comparisons against baseline within randomised groups are often used and can be highly misleading (2011) (160)
The usefulness of ultrasound assessment of amniotic fluid in predicting adverse outcome in prolonged pregnancy: a prospective blinded observational study (2003) (159)
Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology (1996) (158)
The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. (2005) (158)
CONSORT 2010 statement: extension checklist for reporting within person randomised trials (2017) (157)
Statistical reviewing for medical journals. (1998) (157)
Disadvantages of using the area under the receiver operating characteristic curve to assess imaging tests: A discussion and proposal for an alternative approach (2015) (156)
Are Peer Reviewers Encouraged to Use Reporting Guidelines? A Survey of 116 Health Research Journals (2012) (156)
Predictors of physician's smoking cessation advice. (1991) (156)
Time to event (survival) data (1998) (156)
Missing outcomes in randomized trials: addressing the dilemma (2009) (154)
Adults' approval and adolescents' alcohol use. (2004) (154)
The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months (2006) (153)
IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages (2013) (153)
NOMOGRAMS FOR PRECISE DETERMINATION OF BIRTH WEIGHT FOR DATES (1980) (152)
Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. (2013) (151)
Association between analytic strategy and estimates of treatment outcomes in meta-analyses. (2014) (151)
Meta-analysis, Simpson's paradox, and the number needed to treat (2002) (150)
Social factors and height of primary schoolchildren in England and Scotland. (1978) (150)
Evidence for the Selective Reporting of Analyses and Discrepancies in Clinical Trials: A Systematic Review of Cohort Studies of Clinical Trials (2014) (149)
[Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) Checklist and Guide]. (2016) (149)
Computed tomographic colonography: assessment of radiologist performance with and without computer-aided detection. (2006) (147)
Design and analysis of studies to derive charts of fetal size (1993) (147)
The Good Clinical Practice guideline: a bronze standard for clinical research (2005) (146)
Statistics in Medicine: Calculating confidence intervals for regression and correlation (1988) (146)
Methodological challenges in the evaluation of prognostic factors in breast cancer (2004) (146)
Intra‐ and interobserver variability in fetal ultrasound measurements (2012) (145)
Ensuring trial validity by data quality assurance and diversification of monitoring methods (2008) (145)
Statistics Notes: Quartiles, quintiles, centiles, and other quantiles (1994) (144)
Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines (2010) (144)
Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial. (2016) (143)
Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research (2008) (142)
The relationship between tobacco access and use among adolescents: a four community study. (1999) (142)
Health psychology and public health : an integrative approach (1989) (141)
The cost-effectiveness of three smoking cessation programs. (1987) (138)
Correlation in restricted ranges of data (2011) (136)
Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study (2010) (134)
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. (2007) (133)
Methodological challenges in the evaluation of prognostic factors in breast cancer. (1998) (133)
Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers (2010) (132)
Intrauterine growth retardation: Let's be clear about it (1989) (132)
Describing reporting guidelines for health research: a systematic review. (2011) (132)
Mejorar la comunicación de estudios observacionales en epidemiología (STROBE): explicación y elaboración (2009) (132)
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond (2009) (132)
The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention. (2015) (131)
Meta‐analysis combining parallel and cross‐over clinical trials. II: Binary outcomes (2002) (131)
How statistical expertise is used in medical research. (2002) (130)
CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. (2016) (128)
Bias Due to Changes in Specified Outcomes during the Systematic Review Process (2010) (128)
Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales by D. E. Warn, S. G. Thompson and D. J. Spiegelhalter, Statistics in Medicine 2002; 21: 1601–1623 (2005) (128)
Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. (2015) (127)
Models for potentially biased evidence in meta‐analysis using empirically based priors (2009) (127)
Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement (2019) (126)
The INTERGROWTH‐21st fetal growth standards: toward the global integration of pregnancy and pediatric care (2018) (125)
Effect Measures for Meta‒Analysis of Trials with Binary Outcomes (2008) (124)
Reducing the illegal sale of cigarettes to minors. (1989) (124)
Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey (2016) (123)
Bayesians and frequentists (1998) (122)
Modelling prognostic factors in advanced pancreatic cancer (2008) (122)
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines (2009) (122)
The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. (2009) (122)
Statistics and ethics in medical research. Misuse of statistics is unethical. (1980) (120)
Characteristics and participant perceptions of tobacco control coalitions in California (1993) (120)
Repeatability of measurement of fetal nuchal translucency thickness (1995) (120)
Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation (2007) (118)
Prognostic Models: A Methodological Framework and Review of Models for Breast Cancer (2009) (118)
Estimating with confidence (1988) (118)
The effects of combining education and enforcement to reduce tobacco sales to minors. A study of four northern California communities. (1991) (116)
RANDOMISATION : ESSENTIAL FOR REDUCING BIAS (1991) (116)
Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265] (2006) (116)
Design and analysis of longitudinal studies of fetal size (1995) (115)
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials. (2016) (113)
Charts of fetal size: kidney and renal pelvis measurements (2003) (112)
How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing (1999) (112)
Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores (2011) (111)
Improving the reporting of randomised trials: the CONSORT Statement and beyond (2012) (111)
Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units (1998) (110)
DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial (2018) (110)
Charts of fetal size: limb bones (2002) (110)
Enhancing the usability of systematic reviews by improving the consideration and description of interventions (2017) (110)
The hidden effect of time. (1988) (109)
Statistics and ethics in medical research (1981) (109)
CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration. (2017) (108)
Ultrasound‐based gestational‐age estimation in late pregnancy (2016) (108)
Biomarker studies: a call for a comprehensive biomarker study registry (2011) (107)
Exposure to violence and victimization, depression, substance use, and the use of violence by young adolescents. (2000) (107)
Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols (2014) (107)
CONSORT 2010 changes and testing blindness in RCTs (2010) (107)
Meta‐analysis combining parallel and cross‐over clinical trials. III: The issue of carry‐over (2002) (107)
Gestational weight gain standards based on women enrolled in the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: a prospective longitudinal cohort study (2016) (107)
Statistics with confidence. 2nd edition (2000) (106)
Composite Outcomes in Cardiovascular Research: A Survey of Randomized Trials (2008) (106)
Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study (2017) (106)
[Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement (Chinese version)]. (2010) (106)
CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement (2015) (105)
Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model (2016) (105)
Sustained effects of an educational program to reduce sales of cigarettes to minors. (1991) (105)
Statistics notes: Matching (1994) (105)
Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement (2019) (105)
Assessment of and intervention for psychosocial problems in routine oncology practice. (1995) (105)
New Guideline for the Reporting of Studies Developing, Validating, or Updating a Multivariable Clinical Prediction Model: The TRIPOD Statement (2015) (104)
Best (but oft forgotten) practices: testing for treatment effects in randomized trials by separate analyses of changes from baseline in each group is a misleading approach. (2015) (104)
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies]. (2008) (103)
How an Unhealthy Product Is Sold: Cigarette Advertising in Magazines, 1960-1985. (1987) (102)
Alcohol and cigarette advertising on billboards (1991) (100)
Statistics Notes: Missing data (2007) (100)
Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects. (1995) (99)
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement (2010) (98)
Categorising continuous variables. (1991) (97)
The COMET (Core Outcome Measures in Effectiveness Trials) Initiative (2011) (97)
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. (2012) (97)
The Glim System Release 3 Manual (1980) (96)
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis (2016) (95)
The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years (2006) (95)
Update on the endorsement of CONSORT by high impact factor journals: a survey of journal “Instructions to Authors” in 2014 (2016) (95)
Approximating statistical functions by using fractional polynomial regression (1997) (94)
Transfer of technology from statistical journals to the biomedical literature. Past trends and future predictions. (1994) (94)
STRengthening Analytical Thinking for Observational Studies: the STRATOS initiative (2014) (94)
Correlation, regression, and repeated data. (1994) (94)
Avoidable waste of research related to inadequate methods in clinical trials (2015) (93)
Statistics notes: Interaction 3: How to examine heterogeneity (1996) (93)
CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration. (2015) (93)
Parametric v non-parametric methods for data analysis (2009) (92)
A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network (2016) (92)
Statistics Notes: Interaction 1: heterogeneity of effects (1996) (92)
[CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration]. (2008) (92)
Quality of life assessment in clinical cancer research. (1994) (92)
The Quality of Reporting Methods and Results in Network Meta-Analyses: An Overview of Reviews and Suggestions for Improvement (2014) (91)
Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers (2010) (90)
A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity. (2016) (90)
METAN: Stata module for fixed and random effects meta-analysis (2007) (90)
Decision tools in health care: focus on the problem, not the solution (2006) (89)
The CARE Guidelines: Consensus-based Clinical Case Report Guideline Development (2013) (89)
Statistics Notes: Bootstrap resampling methods (2015) (89)
The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review (2011) (89)
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. (2006) (88)
Identification of clinically useful cancer prognostic factors: what are we missing? (2005) (87)
Statistics Notes: Comparing several groups using analysis of variance (1996) (87)
The COMET Initiative database: progress and activities from 2011 to 2013 (2014) (87)
Systematic reviews of diagnostic tests in cancer: review of methods and reporting (2006) (86)
Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. (1993) (86)
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received. (2019) (86)
Visualizing and assessing discrimination in the logistic regression model (2010) (85)
Ítems de referencia para publicar Revisiones Sistemáticas y Metaanálisis: La Declaración PRISMA (2014) (85)
Constraints on publication rights in industry-initiated clinical trials. (2006) (85)
Calculating confidence intervals for regression and correlation. (1988) (84)
Risk stratification for in-hospital mortality in acutely decompensated heart failure. (2005) (83)
CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration (2015) (83)
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review. (2014) (82)
Green tobacco sickness (1998) (82)
Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting (2007) (80)
Das Strengthening the Reporting of Observational Studies in Epidemiology (STROBE-) Statement (2008) (80)
Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery. (2000) (80)
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform (2015) (80)
Monitoring of large randomised clinical trials: a new approach with Bayesian methods (2001) (79)
Improving bioscience research reporting: ARRIVE-ing at a solution (2010) (79)
Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews (2013) (79)
Standardization of fetal ultrasound biometry measurements: improving the quality and consistency of measurements (2011) (79)
In collaboration with the International Stroke Trial Collaborative Group. Indirect comparisons of competing interventions (2005) (78)
Cigarette Advertisements in Magazines: Evidence for a Differential Focus on Women's and Youth Magazines (1988) (78)
Alcohol and Cigarette Advertising on Billboards: Targeting With Social Cues (1996) (78)
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact (2009) (78)
Primer: an evidence-based approach to prognostic markers (2005) (78)
Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. (2011) (78)
Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study (2014) (77)
Poor reporting of multivariable prediction model studies: towards a targeted implementation strategy of the TRIPOD statement (2018) (77)
Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data. (2007) (77)
The content of medical journal Instructions for authors. (2006) (76)
Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond (2004) (76)
Indirect comparison meta-analysis of aspirin therapy after coronary surgery (2003) (76)
National study of health and growth: standards of attained height, weight and triceps skinfold in English children 5 to 11 years old. (1977) (75)
Responsible alcohol service: a study of server, manager, and environmental impact. (1991) (75)
Declaration of transparency for each research article (2013) (75)
Pragmatic trials can be designed as optimal medical care: principles and methods of care trials. (2014) (73)
Serum immunoglobulin concentrations in preschool children measured by laser nephelometry: reference ranges for IgG, IgA, IgM. (1983) (72)
Declaración SPIRIT 2013: definición de los elementos estándares del protocolo de un ensayo clínico* (2015) (72)
Adjustment for continuous confounders: an example of how to prevent residual confounding (2013) (72)
Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial (2015) (72)
Obesity and the outcome of young breast cancer patients in the UK: the POSH study. (2015) (71)
Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. (1986) (71)
Measurement of the fetal mandible—feasibility and construction of a centile chart (1993) (71)
Beneficial Effect of Azathioprine and Prediction of Prognosis in Primary Biliary (1985) (70)
Reporting on Statistical Methods To Adjust for Confounding: A Cross-Sectional Survey (2002) (70)
Standard 5: Selection, Measurement, and Reporting of Outcomes in Clinical Trials in Children (2012) (69)
Evaluation of the Ages and Stages Questionnaires in identifying children with neurosensory disability in the Magpie Trial follow‐up study (2007) (68)
Body composition at birth and its relationship with neonatal anthropometric ratios: the newborn body composition study of the INTERGROWTH-21st project (2017) (68)
Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis. (2013) (67)
Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews (2018) (67)
Correspondence2010 Statement: updated guidelines for reporting parallel group randomised trials (2010) (67)
A survey of the nutritional status of schoolchildren. Relation between nutrient intake and socio-economic factors. (1973) (67)
A framework for evaluating community-based heart disease prevention programs. (1986) (65)
Systematic reviews of clinical decision tools for acute abdominal pain. (2006) (65)
Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials (2004) (65)
The COMET Initiative database: progress and activities update (2015) (2017) (65)
Incremental benefit of computer-aided detection when used as a second and concurrent reader of CT colonographic data: multiobserver study. (2011) (65)
Forest plots in reports of systematic reviews: a cross-sectional study reviewing current practice. (2010) (64)
The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies. (2009) (64)
Improving the relevance and consistency of outcomes in comparative effectiveness research. (2016) (64)
An Extension of the CONSORT Statement (2006) (64)
DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial (2018) (64)
The EQUATOR Network: Enhancing the quality and transparency of health research through the use of reporting guidelines (2008) (63)
External validation of QDSCORE® for predicting the 10‐year risk of developing Type 2 diabetes (2011) (63)
Towards agreement on best practice for publishing raw clinical trial data (2009) (63)
Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study (2013) (63)
CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration. (2017) (63)
Generalisation and extrapolation (1998) (63)
Statistics and ethics in medical research: V--Analysing data. (1980) (62)
COS-STAR: a reporting guideline for studies developing core outcome sets (protocol) (2015) (62)
Analysis of continuous data from small samples (2009) (62)
Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study. (2013) (62)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials (2010) (61)
Statistics Notes: Logarithms (1996) (61)
Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers (2015) (60)
How Cigarettes Are Advertised in Magazines: Special Messages for Special Markets (1991) (60)
Commentary on Quantifying Agreement between Two Methods of Measurement (2002) (60)
Comparability of randomized groups (1984) (60)
Randomised consent designs in cancer clinical trials. (1995) (60)
International standards for symphysis-fundal height based on serial measurements from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: prospective cohort study in eight countries (2016) (59)
Reproducible research practices are underused in systematic reviews of biomedical interventions. (2018) (59)
Tracking eye gaze during interpretation of endoluminal three-dimensional CT colonography: visual perception of experienced and inexperienced readers. (2014) (58)
Statistics Notes: Percentage differences, symmetry, and natural logarithms (2017) (58)
Improving the completeness and transparency of reports of randomized trials in oral health: the CONSORT statement. (2008) (58)
Choosing Important Health Outcomes For Comparative Effectiveness Research: A Systematic Review. (2014) (58)
Statistical reviewing policies of medical journals: caveat lector? (1998) (57)
Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization Trial (2017) (57)
Red Blood Cell Transfusion and Mortality in Trauma Patients: Risk-Stratified Analysis of an Observational Study (2014) (56)
Is the anterior-posterior axis of the fetus specified before implantation in the mouse? (1992) (56)
A CHecklist for statistical Assessment of Medical Papers (the CHAMP statement): explanation and elaboration (2021) (56)
Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials (2009) (56)
The antepartum stillbirth syndrome: risk factors and pregnancy conditions identified from the INTERGROWTH‐21st Project (2016) (56)
Prognosis research: toward evidence-based results and a Cochrane methods group. (2007) (55)
Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol (2007) (55)
Four Proposals to Help Improve the Medical Research Literature (2015) (55)
Anthropometric Characterization of Impaired Fetal Growth: Risk Factors for and Prognosis of Newborns With Stunting or Wasting. (2015) (55)
Estimating sample sizes for continuous, binary, and ordinal outcomes in paired comparisons: practical hints. (1999) (54)
Health effects due to occupational exposure to cobalt blue dye among plate painters in a porcelain factory in Denmark. (1988) (54)
[CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (Chinese version)]. (2010) (54)
THE EFFECT OF GENITAL MYCOPLASMAS ON HUMAN FETAL GROWTH (1981) (53)
Adherence in social context. (2000) (53)
Scoping review on interventions to improve adherence to reporting guidelines in health research (2019) (53)
Statistics and ethics in medical research. VIII-Improving the quality of statistics in medical journals. (1981) (53)
DELTA 2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial (2018) (52)
Statistical Analyses and Methods in the Published Literature: The SAMPL Guidelines* (2014) (52)
The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration (2013) (52)
Reporting bias in diagnostic and prognostic studies: time for action. (2008) (52)
CONSORT 2010 checklist of information to include when reporting a randomised trial * (2010) (51)
Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study (2004) (51)
CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version) (2017) (51)
[The CONSORT statenent: Revised Recommendations For Improving the Quality of Reports of Parallel-Group Randomized Trials]. (2005) (50)
CT colonography interpretation times: effect of reader experience, fatigue, and scan findings in a multi-centre setting (2006) (50)
Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory. (2009) (50)
Influence of some social and environmental factors on the nutrient intake and nutritional status of schoolchildren. (1975) (50)
Uniformity in measuring adherence to reporting guidelines: the example of TRIPOD for assessing completeness of reporting of prediction model studies (2019) (50)
Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings. (2016) (50)
Monitoring human growth and development: a continuum from the womb to the classroom. (2015) (50)
Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review (2010) (50)
Elaboración de directrices para la publicación de investigación biomédica: proceso y fundamento científico (2005) (50)
Is the statistical assessment of papers submitted to the "British Medical Journal" effective? (1983) (49)
Comparison of methods of measuring blood pressure. (1986) (49)
Statistics and ethics in medical research. VI--Presentation of results. (1980) (49)
Psychosocial Factors Associated With Youth Involvement in Community Activities Promoting Heart Health (1998) (49)
Reporting of participant flow diagrams in published reports of randomized trials (2011) (48)
Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal) (2012) (48)
The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS] (2015) (47)
From submission to publication: a retrospective review of the tables and figures in a cohort of randomized controlled trials submitted to the British Medical Journal. (2006) (47)
Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional study (2013) (47)
Statistical reviewing policies of medical journals (1998) (46)
The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. (1995) (46)
The satisfactory growth and development at 2 years of age of the INTERGROWTH-21st Fetal Growth Standards cohort support its appropriateness for constructing international standards (2017) (46)
The satisfactory growth and development at 2 years of age of the INTERGROWTH-21st Fetal Growth Standards cohort support its appropriateness for constructing international standards (2017) (46)
Waiving confidentiality for the greater good (2006) (45)
Turning a blind eye:Testing the success of blinding and the CONSORT statement (2004) (45)
Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries (2018) (45)
Statistics Notes: Presentation of numerical data (1996) (45)
EQUATOR: reporting guidelines for health research. (2008) (45)
Identifying approaches for assessing methodological and reporting quality of systematic reviews: a descriptive study (2017) (43)
Reporting of clinical trials: a review of research funders' guidelines (2008) (43)
Statistics Notes: Missing outcomes in randomised trials (2013) (43)
A note on the calculation of expected survival, illustrated by the survival of liver transplant patients. (1991) (43)
Baseline comparisons in randomized clinical trials. (1991) (42)
Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study (2009) (42)
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design (2019) (41)
Sensitivity and specificity and their confidence intervals cannot exceed 100% (1999) (41)
Comparisons within randomised groups can be very misleading (2011) (41)
Sharing Individual Participant Data from Clinical Trials: An Opinion Survey Regarding the Establishment of a Central Repository (2014) (41)
Lower limb arthroplasty: can we produce a tool to predict outcome and failure, and is it cost-effective? An epidemiological study (2017) (41)
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design (2019) (41)
An evaluation of a mass media campaign to encourage parents of adolescents to talk to their children about sex. (2006) (41)
Suboptimal analysis using 'optimal' cutpoints. (1998) (41)
Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials—ESORT) (2015) (40)
Confidence intervals illuminate absence of evidence (2004) (40)
Flaws in the application and interpretation of statistical analyses in systematic reviews of therapeutic interventions were common: a cross-sectional analysis. (2018) (40)
Modeling the effects of continuous risk factors. (2000) (40)
The COMET initiative database: progress and activities update (2014) (2015) (40)
Responsible reporting of health research studies: transparent, complete, accurate and timely. (2010) (39)
Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge. (2013) (39)
The CONSORT Statement: Application within and adaptations for orthodontic trials. (2015) (39)
Very large treatment effects in randomised trials as an empirical marker to indicate whether subsequent trials are necessary: meta-epidemiological assessment (2016) (39)
Support for reporting guidelines in surgical journals needs improvement: A systematic review. (2016) (39)
Obstacles to and future goals of ten comprehensive community health promotion projects (1991) (39)
Deficiencies in the publication and reporting of the results of systematic reviews presented at scientific medical conferences. (2015) (39)
Assessing Agreement between Methods of Measurement. (2017) (39)
NY‐ESO‐1 specific antibody and cellular responses in melanoma patients primed with NY‐ESO‐1 protein in ISCOMATRIX and boosted with recombinant NY‐ESO‐1 fowlpox virus (2015) (39)
Assessing birth weight-for-dates on a continuous scale. (1980) (39)
FETAL HAEMOGLOBIN MEASUREMENT IN THE ASSESSMENT OF RED CELL ISOIMMUNISATION (1988) (38)
Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots. (2008) (38)
Evidence-based practice in radiology: steps 3 and 4--appraise and apply systematic reviews and meta-analyses. (2007) (38)
Effects of on-pump and off-pump surgery in the Arterial Revascularization Trial. (2015) (38)
Community-Based Interdisciplinary Research: Introduction to the Special Issue (2006) (38)
Reporting of effect direction and size in abstracts of systematic reviews. (2011) (38)
Tobacco farmers and diversification: opportunities and barriers. (1996) (38)
Peer reviewers identified spin in manuscripts of nonrandomized studies assessing therapeutic interventions, but their impact on spin in abstract conclusions was limited. (2016) (37)
The CARE guidelines: consensus-based clinical case reporting guideline development. (2013) (37)
Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978-1994. (1996) (36)
Challenges in Sustaining Public Health Interventions (2009) (36)
Updating standards for reporting diagnostic accuracy: the development of STARD 2015 (2016) (36)
The Problem of Subgroup Analyses: An Example from a Trial on Ruptured Intracranial Aneurysms (2011) (36)
Predictors of crop diversification: a survey of tobacco farmers in North Carolina (USA) (1998) (36)
Prognosis after liver transplantation for primary biliary cirrhosis. (1989) (36)
Methods for Specifying the Target Difference in a Randomised Controlled Trial: The Difference ELicitation in TriAls (DELTA) Systematic Review (2014) (36)
Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial (2016) (35)
Quality control of ultrasound for fetal biometry: results from the INTERGROWTH‐21st Project (2018) (35)
Statistics notes Variables and parameters (1999) (35)
A method for combining matched and unmatched binary data. Application to randomized, controlled trials of photocoagulation in the treatment of diabetic retinopathy. (1989) (35)
Importance of Transparent Reporting of Health Research (2014) (35)
Reporting guidelines of health research studies are frequently used inappropriately. (2020) (35)
Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials—ESORT) (2017) (34)
Development of Design-a-Trial, a knowledge-based critiquing system for authors of clinical trial protocols. (1994) (34)
Animal Research: Reporting In Vivo Experiments (2010) (34)
The influence of CONSORT on the quality of reporting of randomised controlled trials: an updated review (2011) (33)
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design (2020) (33)
A systematic review of the use of an expertise-based randomised controlled trial design (2015) (33)
Tobacco promotions in the hands of youth (1995) (33)
Peer review of statistics in medical research. Reporting power calculations is important. (2002) (33)
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles (2017) (33)
Polyp measurement using CT colonography: agreement with colonoscopy and effect of viewing conditions on interobserver and intraobserver agreement. (2006) (33)
The time has come to register diagnostic and prognostic research. (2014) (32)
The National Institutes of Health and guidance for reporting preclinical research (2015) (32)
Statistics and ethics in medical research: study design. (1980) (32)
Circumferential measurements in the assessment of synovitis of the knee. (1979) (32)
The ARRIVE guidelines Animal Research: Reporting In Vivo Experiments (2010) (32)
Lead editorial: Trials – using the opportunities of electronic publishing to improve the reporting of randomised trials (2006) (32)
Predictors of physicians' smoking cessation advice (1992) (32)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement (2015) (32)
Statistics and ethics in medical research. VII--Interpreting results. (1980) (31)
Why We Need Confidence Intervals (2005) (31)
Systematic review of the methodological quality of studies designed to create neonatal anthropometric charts (2015) (31)
Vitamins to prevent cancer: supplementary problems (2004) (31)
Evidence-Based Assessment and Application of Prognostic Markers: The Long Way from Single Studies to Meta-Analysis (2006) (31)
A meta-analysis of echocardiographic measurements of the left heart for the development of normative reference ranges in a large international cohort: the EchoNoRMAL study. (2014) (31)
Problems in dichotomizing continuous variables. (1994) (31)
Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design (2013) (30)
Clinical and microbiological study of non-gonococcal urethritis with particular reference to non-chlamydial disease. (1981) (30)
The SPIRIT 2013 statement--defining standard protocol items for trials. (2015) (30)
Reaching consensus on reporting patient and public involvement (PPI) in research: methods and lessons learned from the development of reporting guidelines (2017) (30)
Statistics Notes: What is a percentage difference? (2017) (30)
Categorizing Continuous Variables (2005) (30)
Using fractional polynomials to model curved regression relationships (1995) (30)
A fair trial? (1984) (30)
Public Health Advocacy: Creating Community Change to Improve Health (1994) (29)
CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version). (2017) (29)
Invited commentary: methodological issues in the design and analysis of randomised trials (2017) (29)
Standard 4: Determining Adequate Sample Sizes (2012) (28)
Interaction 2 : compare effects size not P values (1996) (28)
Revision of the ARRIVE guidelines: rationale and scope (2018) (28)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. (2007) (28)
Method for tracking eye gaze during interpretation of endoluminal 3D CT colonography: technical description and proposed metrics for analysis. (2013) (28)
Terminal digit preference biases polyp size measurements at endoscopy, computed tomographic colonography, and histopathology (2016) (28)
Inadequate reporting of controlled trials as short reports (1998) (28)
Confidence intervals for research findings (1992) (28)
Conceptual and strategic foundations for effective media campaigns for preventing the spread of HIV infection (1990) (28)
The Oxford Conception Study design and recruitment experience. (2006) (28)
Future Directions for Youth Empowerment: Commentary on Application of Youth Empowerment Theory to Tobacco Control (2004) (28)
Polyp measurement and size categorisation by CT colonography: effect of observer experience in a multi-centre setting (2006) (27)
Ensayos clínicos aleatorizados comunitarios (CONSORT CLUSTER) (2005) (27)
The natural history of conducting and reporting clinical trials: interviews with trialists (2015) (27)
Within trial variation--a false trail? (1998) (27)
Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model (1990) (26)
Writing a research article that is fit for purpose: EQUATOR Network and reporting guidelines (2009) (26)
metan – a command for meta-analysis in Stata (2015) (26)
Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal). (2013) (26)
Allocation concealment in clinical trials. (2002) (26)
Inadequate post-publication review of medical research (2010) (26)
Estudios de precisión diagnóstica (STARD) y pronóstica (REMARK) (2005) (26)
Coronary artery bypass grafting in high-RISk patients randomised to off- or on-Pump surgery: a randomised controlled trial (the CRISP trial). (2014) (26)
Teens as Advocates for Substance use Prevention: Strategies for Implementation (2002) (26)
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design (2018) (26)
Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK (2012) (26)
A note on the uncertainty of a survival probability estimated from Cox's regression model (1986) (26)
In defence of logarithmic transformations (2013) (25)
Estimation of gestational age in early pregnancy from crown-rump length when gestational age range is truncated: the case study of the INTERGROWTH-21st Project (2013) (25)
ACP Journal Club. Editorial: Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines. (2009) (25)
Association of cardiovascular trial registration with positive study findings: Epidemiological Study of Randomized Trials (ESORT). (2015) (25)
Statistical analysis of comparison between laboratory methods. (1991) (25)
Incidence and clinical implications of intraoperative bilateral internal thoracic artery graft conversion: Insights from the Arterial Revascularization Trial (2018) (25)
Does journal endorsement of reporting guidelines influence the completeness of reporting of health research? A systematic review protocol (2012) (25)
Is there a case for an international medical scientific press council? (1994) (25)
Meta-analyses of randomised trials: when the whole is more than just the sum of the parts. (1996) (25)
Use of the Internet by print medical journals in 2003 to 2009: a longitudinal observational study. (2011) (25)
Transparent Reporting of Multivariable Prediction Models in Journal and Conference Abstracts: TRIPOD for Abstracts (2020) (25)
Plotting Probability Ellipses (1978) (25)
CONSORT 2010 comments (2010) (25)
Multi-Reader Multi-Case Studies Using the Area under the Receiver Operator Characteristic Curve as a Measure of Diagnostic Accuracy: Systematic Review with a Focus on Quality of Data Reporting (2014) (25)
Strategies for Community Health Intervention: Promises, Paradoxes, Pitfalls (1995) (25)
Childhood obesity intervention studies: A narrative review and guide for investigators, authors, editors, reviewers, journalists, and readers to guard against exaggerated effectiveness claims (2019) (24)
Making research articles fit for purpose: structured reporting of key methods and findings (2015) (24)
Statistical analyses and methods in the published literature: The SAMPL guidelines (2016) (24)
Rating of Included Trials on the Efficacy-Effectiveness Spectrum: development of a new tool for systematic reviews. (2017) (24)
Meta-analysis and The Cochrane Collaboration: 20 years of the Cochrane Statistical Methods Group (2013) (24)
Prognostic model research (2019) (24)
Systematic Review of Multiple Studies of Prognosis: The Feasibility of Obtaining Individual Patient Data (2007) (24)
More informative abstracts. (1987) (24)
Microcytosis, iron deficiency, and thalassaemia in preschool children. (1990) (24)
Detection of extracolonic pathologic findings with CT colonography: a discrete choice experiment of perceived benefits versus harms. (2014) (24)
A nutritional surveillance study. (1973) (24)
Towards a framework for analysis of eye-tracking studies in the three dimensional environment: a study of visual search by experienced readers of endoluminal CT colonography. (2014) (24)
Reporting medical research (2013) (24)
Quantitation in inflammatory bowel disease using computerised interactive image analysis. (1985) (23)
Uncertainty and sampling error (2014) (23)
Design choices for observational studies of the effect of exposure on disease incidence (2019) (23)
Aflatoxin and outcome from acute lower respiratory infection in children in The Philippines. (1995) (23)
Family history and outcome of young patients with breast cancer in the UK (POSH study) (2015) (23)
CHecklist for statistical Assessment of Medical Papers: the CHAMP statement (2021) (23)
Fetal growth velocity standards from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project (2020) (23)
A cross-sectional bibliometric study showed suboptimal journal endorsement rates of STROBE and its extensions. (2019) (23)
Major geographical variations in elective coronary revascularization by stents or surgery in England. (2015) (23)
Chapter 13. Systematic Reviews of Evaluations of Prognostic Variables (2008) (22)
Improving the Clarity and Transparency of Reporting Health Research: a Shared Obligation and Responsibility (2008) (22)
Measurement of colonic polyps by radiologists and endoscopists: Who is most accurate? (2008) (22)
[Developing guidelines for reporting healthcare research: scientific rationale and procedures]. (2005) (22)
Scientific hypotheses can be tested by comparing the effects of one treatment over many diseases in a systematic review. (2014) (22)
Azathioprine and prognosis in primary biliary cirrhosis. (1986) (22)
Defining publication bias: protocol for a systematic review of highly cited articles and proposal for a new framework (2013) (22)
Creating Capacity: Establishing a Health Education Research Agenda for Special Populations (1995) (22)
Adherence of trials of operative intervention to the CONSORT statement extension for non-pharmacological treatments: a comparative before and after study (2012) (22)
Exploring the role and function of trial steering committees: results of an expert panel meeting (2015) (22)
Antecedents to supportive supervision: An examination of biographical data (2013) (22)
Accuracy in detecting inadequate research reporting by early career peer reviewers using an online CONSORT-based peer-review tool (COBPeer) versus the usual peer-review process: a cross-sectional diagnostic study (2019) (22)
The influence of availability of free school milk on the height of children in England and Scotland. (1979) (22)
Effects of a drug overdose in a television drama on knowledge of specific dangers of self poisoning: population based surveys (1999) (22)
Misleading statistics: errors in textbooks, software and manuals. (1988) (22)
Harms of outcome switching in reports of randomised trials: CONSORT perspective (2017) (21)
COMMENT ON: TUMOR ANGIOGENESIS AS A PROGNOSTIC ASSAY FOR INVASIVE DUCTAL BREAST CARCINOMA. AUTHORS' REPLY (1995) (21)
Data sharing among data monitoring committees and responsibilities to patients and science (2013) (21)
Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney® scores using a primary care database. (2012) (21)
Development of a combined database for meta‐epidemiological research (2010) (21)
Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model. (2013) (20)
Statistical methodology for constructing gestational age‐related charts using cross‐sectional and longitudinal data: The INTERGROWTH‐21st project as a case study (2018) (20)
Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1‐year outcomes in the Arterial Revascularization Trial† (2017) (20)
Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas). (2013) (20)
The executive mind: leader self‐talk, effectiveness and strain (2013) (20)
Patients' & Healthcare Professionals' Values Regarding True- & False-Positive Diagnosis when Colorectal Cancer Screening by CT Colonography: Discrete Choice Experiment (2013) (20)
Guidelines for Reporting Health Research: A User's Manual: Simera/Guidelines for Reporting Health Research: A User's Manual (2014) (20)
MISLEADING PAPER ABOUT MISLEADING STATISTICS (1985) (20)
research methods & reporting (2010) (20)
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach (2012) (20)
Statistics and ethics in medical research. Collecting and screening data. (1980) (19)
Improving the quality of reporting acupuncture interventions: describing the collaboration between STRICTA, CONSORT and the Chinese Cochrane Centre (2009) (19)
Using Reporting Guidelines Effectively to Ensure Good Reporting of Health Research (2014) (19)
Effect of integration of injury control information into a high school physics course. (1996) (19)
Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model. (2013) (19)
CONSORT 2010 statement: extension checklist for reporting within person randomised trials (2019) (19)
Letter: Peak-flow meter and peak-flow gauge. (1974) (19)
Systematic review: Bias in imaging studies - the effect of manipulating clinical context, recall bias and reporting intensity (2012) (19)
Size of clinical trials. (1983) (19)
Standard 3: Data Monitoring Committees (2012) (18)
Off-pump vs. on-pump CABG: are we any closer to a resolution? (2012) (18)
Preterm feeding recommendations are achievable in large-scale research studies (2016) (18)
Off‐pump versus on‐pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial (2017) (18)
Estimation of gestational age at birth--comparison of two methods. (1979) (18)
Policy Alternatives for Reducing Tobacco Sales to Minors: Results from a National Survey of Retail Chain and Franchise Stores (1992) (18)
Review and publication of protocol submissions to Trials – what have we learned in 10 years? (2016) (18)
Design and other methodological considerations for the construction of human fetal and neonatal size and growth charts (2018) (18)
Simulation studies of surrogate endpoint validation using single trial and multitrial statistical approaches. (2007) (17)
The Use of the World Wide Web by Medical Journals in 2003 and 2005: An Observational Study (2007) (17)
Declaración de la Iniciativa STOBE (Strengthening the Reporting of Observational Studies in Epidemiology): directrices para informar sobre los estudios observacionales (2007) (17)
Report of the Tobacco Policy Research Study Group on Access to Tobacco Products in the United States (1992) (17)
Assessing new methods of clinical measurement. (2009) (17)
Linked publications from a single trial: a thread of evidence (2014) (17)
Statistics in the medical literature: 3. (1999) (17)
PRESENTATION OF VARIABILITY (1986) (17)
CT colonography: a systematic review of standard of reporting for studies of computer-aided detection. (2008) (16)
CONSORT statement on the reporting standards of clinical trials (1997) (16)
What Randomized Trials and Systematic Reviews Can Offer Decision Makers (1999) (16)
Teaching non‐specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study (2000) (16)
The effect of computer-aided detection markers on visual search and reader performance during concurrent reading of CT colonography (2015) (16)
Prediction of moderate and high grade vesicoureteral reflux after a first febrile urinary tract infection in children: construction and internal validation of a clinical decision rule. (2011) (16)
Interventions to improve adherence to reporting guidelines in health research: a scoping review protocol (2017) (16)
Difference versus Mean Plots (1997) (16)
Baseline comparisons in clinical trials (1990) (16)
Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients (2020) (16)
Adherence to reporting guidelines increases the number of citations: the argument for including a methodologist in the editorial process and peer-review (2019) (16)
Erratum: the National Institutes of Health and guidance for reporting preclinical research (2015) (16)
Dosimetry of renal radiopharmaceuticals: the importance of bladder radioactivity and a simple aid for its estimation. (1981) (16)
From Clinical Trials to Highly Trustable Clinical Trials: Blockchain in Clinical Trials, a Game Changer for Improving Transparency? (2019) (16)
Randomisation. (1991) (16)
Writing a research article that is “fit for purpose”: EQUATOR Network and reporting guidelines (2009) (16)
Authors should make their data available (2001) (16)
Design flaws in EuroSCORE II. (2013) (15)
Evaluating community‐level health promotion and disease prevention interventions (1989) (15)
Confidence - and clinical importance - in research findings (1990) (15)
One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial (2017) (15)
guidelines for reporting observational studies studies in epidemiology (STROBE) statement: Strengthening the reporting of observational (2007) (15)
CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Simplified Chinese Version) (2017) (15)
Assessment of the Incremental Benefit of Computer-Aided Detection (CAD) for Interpretation of CT Colonography by Experienced and Inexperienced Readers (2015) (15)
Assessing Prognosis from Nonrandomized Studies: An Example from Brain Arteriovenous Malformations (2011) (15)
Uncertainty beyond sampling error (2014) (15)
Systematic review of the methodological and reporting quality of case series in surgery (2016) (15)
Funding of North Carolina tobacco control programs through the Master Settlement Agreement. (2006) (15)
Avoiding bias in trials in which allocation ratio is varied (2018) (15)
Persistent and recurrent non-gonococcal urethritis without evidence of current infection. (1982) (14)
Peer review of statistics in medical research [2] (multiple letters) (2002) (14)
Statistics: necessary and important (1986) (14)
Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review (2018) (14)
MR of visual pathways in patients with neurofibromatosis. (1987) (14)
The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer (2012) (14)
Fetal biometry: how well can offline measurements from three‐dimensional volumes substitute real‐time two‐dimensional measurements? (2013) (14)
Design-a-trial: a rule-based decision support system for clinical trial design (2004) (14)
Statistical guidelines for contributors to medical journals (1983) (14)
Escherichia coli infection in mice and impaired fetal development. (1978) (14)
Commentary: strengthening the reporting of observational epidemiology the STROBE statement. (2007) (14)
[Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) Checklist and Guide]. (2016) (14)
External validation and updating of a prognostic survival model 1 (2010) (14)
The contribution made by school milk to the nutrition of primary schoolchildren (1975) (14)
Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensus (2016) (14)
45A Failure to conceal treatment allocation schedules in trials influenced estimates of treatment effects (1994) (14)
An objective assessment of synovitis of the knee: measurement of the size of the suprapatellar pouch on xeroradiography. (1980) (13)
Prevention in Mental Health (1989) (13)
Study to predict which elderly patients will fall shows difficulties in deriving and validating a model (1997) (13)
Can we be certain that storage duration of transfused red blood cells does not affect patient outcomes? (2019) (13)
ROC curves and confidence intervals: getting them right (2000) (13)
Transparent Reporting of Trials Is Essential (2013) (13)
Reporting guidelines for oncology research: helping to maximise the impact of your research (2018) (13)
Protocols, probity, and publication (2009) (13)
[Constraints on publication rights in industry-initiated clinical trials--secondary publication]. (2006) (13)
Resources for authors of reports of randomized trials: harnessing the wisdom of authors, editors, and readers (2011) (13)
The normal distribution (1995) (13)
Citation Impact was Highly Variable For Reporting Guidelines of Health Research: A Citation Analysis. (2020) (13)
Patients' preferences and randomised trials (1996) (13)
Bland-Altman methods for comparing methods of measurement and response to criticisms (2020) (12)
Exploration of Analysis Methods for Diagnostic Imaging Tests: Problems with ROC AUC and Confidence Scores in CT Colonography (2014) (12)
Erratum: International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21 Project (Lancet (2014) 384 (869-879)) (2014) (12)
Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop. (2019) (12)
Reporting of a Publicly Accessible Protocol and Its Association With Positive Study Findings in Cardiovascular Trials (from the Epidemiological Study of Randomized Trials [ESORT]). (2015) (12)
How to Develop a Reporting Guideline (2014) (12)
Newspaper and wire service coverage of tobacco farmers. (1999) (12)
Correspondence Re: de Jong JS, van Diest PJ, and Baak JPA (1995). Methods in laboratory investigation: analysis of agreement rather than correlation in assessing heterogeneity and reproducibility of vessel counts in breast cancer. (1996) (12)
Reporting clinical research: guidance to encourage accurate and transparent research reporting. (2012) (12)
‘Allocation concealment’: the evolution and adoption of a methodological term (2018) (12)
Feasibility study to examine discrepancy rates in prespecified and reported outcomes in articles submitted to The BMJ (2016) (11)
Children's understanding of health and illness concepts: a preventive health perspective (1985) (11)
Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists’ practice (2014) (11)
Use of confidence intervals to indicate uncertainty in research findings (1996) (11)
What do children aged 5 to 11 years old know about the sun and skin cancer? The practical difficulties of international collaborative research when analysis of language is involved (1997) (11)
Confidence intervals in research evaluation (1992) (11)
Brackets (parentheses) in formulas (2011) (11)
Obesity and the outcome of young breast cancer patients in the UK: the POSH study. (2015) (11)
Challenges in Evaluating Complex Decision Support Systems: Lessons from Design-a-Trial (2001) (11)
Assessing risk of bias in studies that evaluate health care interventions: recommendations in the misinformation age. (2018) (11)
Do declarative titles affect readers’ perceptions of research findings? A randomized trial (2016) (11)
Autumn Books: Caveat doctor: a grim tale of medical statistics textbooks (1987) (11)
Readiness to Change: Newspaper Coverage of Tobacco Farming and Diversification (2000) (11)
North Carolina tobacco farmers' changing perceptions of tobacco control and tobacco manufacturers. (2009) (11)
Where Next for Evidence Synthesis of Prognostic Marker Studies? Improving the Quality and Reporting of Primary Studies to Facilitate Clinically Relevant Evidence-Based Results (2007) (11)
70 Choosing an appropriate dichotomous effect measure for meta-analysis: Empirical evidence of the appropriateness of the odds ratio and relative risk (1997) (10)
Analysis of serial measurements in medical research: Authors' reply (1990) (10)
Time trends in breast cancer survival: experience in a single centre, 1975-89. (1998) (10)
Relation between treatment benefit and underlying risk in meta-analysis - Standard of ''label invariance'' should not abandoned - Author's reply (1996) (10)
Churches, tobacco farmers, and community sustainability: Insights from the tobacco south (2000) (10)
La Declaración CONSORT: Recomendaciones revisadas para mejorar la calidad de los informes de ensayos aleatorizados de grupos paralelos (2017) (10)
The Cochrane Collaboration (1999) (10)
Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD Statement (2015) (10)
Reporting of randomised factorial trials was frequently inadequate. (2020) (10)
More Informative Abstracts Revisited * (1996) (10)
Some methodological issues in the design and analysis of cluster randomised trials (2018) (10)
Unjustified Restrictions on Letters to the Editor (2005) (10)
Racial differences in red cell indices. (1986) (10)
Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial) (2018) (10)
[The CONSORT statement for cluster randomised trials]. (2005) (9)
Studies Investigating Prognostic Factors: Conduct and Evaluation (2006) (9)
Completeness of reporting of case reports in high‐impact medical journals (2020) (9)
Calibration of EuroSCORE II. (2013) (9)
Context and process: An ecological view of the interdependence of practice and research: An invited address by James G. Kelly (1986) (9)
Combining results from several clinical trials (1988) (9)
Presentation of continuous outcomes in randomised trials: an observational study (2012) (9)
Choosing the target difference (‘effect size’) for a randomised controlled trial - DELTA2 guidance protocol (2017) (9)
School meals and the nutrition of schoolchildren. (1975) (9)
Urinary abnormalities in non gonococcal urethritis. (1981) (9)
Clinical trials: Subgroup analyses in randomized trials—more rigour needed (2015) (9)
Commentary: Systematic reviewers face challenges from varied study designs. (2002) (9)
Covariate Imbalance, Adjustment for † (2014) (9)
Measurement of carotid stenosis (1994) (9)
Disease Prevention in Communities: The Stanford Heart Disease Prevention Program. (1988) (9)
More Informative Abstracts Revisited (1991) (9)
Prognostic factor research (2019) (8)
Test for trend across ordered groups revisited (1997) (8)
REMARK (REporting Recommendations for Tumor MARKer Prognostic Studies) (2014) (8)
Statisticians in Medical Schools (1990) (8)
W1205 How Variable Is the Mayo Score Between Observers and Might This Affect Trial Recruitment or Outcome (2009) (8)
Blinding is better than masking (2007) (8)
Building a metaphor: Another brick in the wall? (2012) (8)
Number needed to treat: properties and problems - Comments (2000) (8)
A meta-analysis of hormone replacement therapy for fracture prevention. (2001) (8)
COMET IV meeting summary (2015) (7)
Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial – the development of the DELTA2 guidance (2018) (7)
Adherence of trials of operative intervention to the CONSORT statement (2014) (7)
EVALUATION OF A NEW BLOOD GLUCOSE METER (1987) (7)
International Agency for Research Against Cancer (IARC) (2005) (7)
The quality of systematic reviews. High quality reporting of both randomised trials and systematic reviews should be priority. (2000) (7)
Interpreting the number needed to treat. (2002) (7)
CONSORT statement requires closer examination (2002) (7)
Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT (2018) (7)
Influence of peer review on the reporting of primary outcome(s) and statistical analyses of randomised trials (2018) (7)
Covariate Imbalance, Adjustment for (2005) (7)
Randomized Trials for Improving the Quality of Reports of Parallel-Group The CONSORT Statement: Revised Recommendations (2009) (7)
Building a business case for developing supportive supervisors (2013) (6)
Ambiguities and Confusions Between Reporting and Conduct (2014) (6)
Completeness of reporting of randomised controlled trials including people with transient ischaemic attack or stroke: A systematic review (2018) (6)
Polyp size measurement by CT colonography: Effect of viewing conditions on inter- and intra-observer agreement, and agreement with colonoscopy (2004) (6)
The rest of the challenge: Position statement on employment opportunities. (1983) (6)
Utilization of a telephone cancer information program by symptomatic people (2005) (6)
Summing up. The science of reviewing research, Richard J. Light and David B. Pillemer, Harvard University Press, Cambridge, Mass., 1984. No. of pages: x+191. Price: £6.25 (paperback); £14.95 (hardback) (1986) (6)
Consolidated standards of reporting trials (CONSORT) and the quality of reporting of randomized controlled trials (2010) (6)
Poor-Quality Medical Research (2017) (6)
A protocol of a cross-sectional study evaluating an online tool for early career peer reviewers assessing reports of randomised controlled trials (2017) (6)
Empirical evidence for selective reporting of outcomes in randomised controlled trials (2003) (6)
Five years of Trials (2011) (6)
Erratum: The logrank test (British Medical Journal (1 May) (1073)) (2004) (6)
Proceedings of the 4th World Conference on Research Integrity (2016) (6)
Statistics in Medical Papers (1977) (5)
CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement (2016) (5)
REporting recommendations for tumor MARKer prognostic studies (REMARK). (2005) (5)
Reporting the clinical importance of randomized controlled trials. (2002) (5)
Octreotide infusion versus injection sclerotherapy (1993) (5)
Tobacco Farming and Public Health: Attitudes of the General Public and Farmers (2010) (5)
Tobacco Farmers and Tobacco Manufacturers: Implications for Tobacco Control in Tobacco-Growing Developing Countries (2008) (5)
The need for consensus, consistency, and core outcome sets in perioperative research (2016) (5)
The EQUATOR Network: facilitating transparent and accurate reporting of health research (2008) (5)
Numbers needed to treat derived from meta-analysis. Length of follow up is poorly reported. (1999) (5)
Authors have rights too. (1993) (5)
Statistics notes: Correlation in restricted ranges of data (2011) (5)
Development of guidance for statistical analysis plans (SAPs) for clinical trials (2015) (5)
COMET V meeting summary (2015) (5)
Is the relationship among outcome variables shown in randomized trials? (2015) (5)
Guidance to detect, evaluate and prevent the problem of selective reporting in trial publications (2013) (5)
Randomized Controlled Trials With Statistically Nonsignificant Results (2010) (5)
Underreporting of Conflicts of Interest Among Trialists : A Cross-sectional Study (2013) (5)
Re: Reporting recommendations for tumor marker prognostic studies (REMARK) - Reply (2005) (5)
Confidence interval for odds ratio. (2000) (5)
Response to Rezaeian: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) extension for ecological studies. (2014) (5)
Teenagers Participate in Tobacco Promotions (1995) (5)
Reporting characteristics of non-primary publications of results of randomized trials: a cross-sectional review (2013) (5)
Selective reporting in clinical trials - an examination of discrepancy rates in pre-specified and reported outcomes in articles submitted to the BMJ (2015) (5)
1049 Identification of Items to Be Included in An Ulcerative Colitis Endoscopic Index of Severity (UCEIS) (2009) (4)
P151 - How variable is the Mayo score between observers and might this affect trial recruitment or outcome? (2009) (4)
The CONSORT Statement. Revised recommendations on improving the quality of reports on parallel-design randomized studies (2005) (4)
Randomisation in the SYMPHONY trial (2000) (4)
Erratum to: Millennials at Work: What We Know and What We Need to Do (If Anything) (2011) (4)
Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, rheumatologist (2017) (4)
A systematic review of methods for specifying the target difference in randomised controlled trials (delta review) (2013) (4)
Conduct and Reporting of Clinical Research (2005) (4)
Measuring Need and Demands in Evaluation Research (1985) (4)
A randomised phase II study of interferon alpha alone or in combination with thalidomide in metastatic renal cancer (2004) (4)
P05.50. CONSORT extension for N-of-1 trials (CENT) guidelines (2012) (4)
Improving Design and Analysis of Research: Lessons from Clinical Research (2004) (4)
Commentary Within Trial Variation—A False Trail? (1998) (4)
Design, analysis and reporting of multi-arm trials and strategies to address multiple testing. (2020) (4)
Re: Visualizing length of survival in time-to-event studies: A complement to Kaplan-Meier plots - Response (2008) (4)
A systematic review of the use of an expertise-based randomised trial design (2015) (4)
How well documented are testing strategies and outcome measurement methods in trials of tests? A comparison of reporting quality in test-treatment and monitoring RCTS (2013) (4)
Abstract S2-03: Does BRCA status affect outcome in young breast cancer patients? Results from the prospective study of outcomes in sporadic and hereditary breast cancer (POSH) (2017) (4)
Relating change to initial value. (1991) (4)
Current statistical issues in clinical cancer research. (1993) (4)
Sequencing Issues in Health Behavior Program Development (2001) (4)
Prediction of High-Grade Vesico-Ureteral Reflux after a First Urinary Tract Infection in Children: Construction and Internal Validation of a Clinical Decision Rule (2010) (4)
Intervalos de confianza y no valores P: estimación en vez de pruebas de hipótesis (1993) (4)
Ultrasound estimation of gestational age. (1979) (4)
A systematic review protocol for reporting deficiencies within surgical case series (2015) (4)
[Diagnostic (STARD) and prognostic (REMARK) studies]. (2005) (4)
Importance of the distinction between quality of methodology and quality of reporting. (2017) (3)
Measurement of muscle fibre diameter by computer-aided image analysis (1981) (3)
Health policy approaches to reduce adolescent risk behavior and adverse health consequences. (2009) (3)
Preventing Leader Derailment—A Strategic Imperative for Public Health Agencies (2018) (3)
Effect size estimation as an essential component of statistical analysis. (2010) (3)
[Selective reporting of positive outcomes in randomised trials--secondary publication.. A comparison of protocols with published reports]. (2005) (3)
β blockers in patients with heart failure and atrial fibrillation – Authors' reply (2015) (3)
Correlation, regression, and repeated data: Authors' reply (1994) (3)
New guideline for the reporting of studies developing, validating, or updating a prediction model. (2015) (3)
Reporting noninferiority trials--reply. (2013) (3)
A22 Methodological quality in randomized trials and statistical heterogeneity in meta-analyses (1996) (3)
WHICH ACTIVITY INDEX FOR ULCERATIVE COLITIS? EVALUATION OF INTER-OBSERVER VARIATION IN CLINICAL, ENDOSCOPIC AND COMPOSITE INDICES (2009) (3)
Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis (2017) (3)
PROGNOSTIC MODELS: CLINICALLY USEFUL OR SIMPLY FORGOTTEN (1995) (3)
Reporting guidelines: looking back from the future. (2008) (3)
The benefits and harms of breast cancer screening (2013) (3)
Correction to funnel plot (1999) (3)
Misleading interpretation of results from a small study. (1994) (3)
Some reflections on the evolution of meta‐analysis (2015) (3)
Units of analysis (1997) (3)
Atrial fibrillation and the risks of cardiovascular disease , renal disease and death : a meta-analysis (2016) (3)
Surveys of medical practice (1993) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
Fetal malnutrition-the price of upright posture? (1979) (3)
Individually and Cluster Randomised Trials (2015) (3)
Sample Size Calculations for Designing Clinical Proteomic Profiling Studies Using Mass Spectrometry (2012) (3)
Randomisation: Author's reply (1991) (3)
Das CONSORT Statement (2005) (3)
Fisher and Bradford Hill: a discussion (2003) (2)
LONG-TERM EVALUATION OF MECHANICAL HEART VALVES (1989) (2)
3. Effective care in pregnancy and childbirth. I. Chalmers, M. Enkin and M. J. N. C. Keirse (eds), Oxford University press, Oxford, 1989. no. of pages: xxxiv + 1516 (in two volumes). price: £225. isbn: 0‐19‐261558‐0 and 0‐19‐261880‐6 (1992) (2)
Fetal growth and ratio of placental weight to birth weight. (1992) (2)
Risk of bacterial infection from allogeneic blood transfusion (1997) (2)
Charts of fetal measurement (1999) (2)
Simulation modelling to identify optimal monitoring strategies: the use of the elf biomarker in liver disease monitoring (2013) (2)
BMJ statistical errors (2004) (2)
Core outcome sets and the COMET (core outcome measures in effectiveness trials) initiative; improving the efficiency and value of the research process (2012) (2)
P086 - Which activity index for ulcerative colitis (UC)? Evaluation of inter-observer variation in clinical, endoscopic and composite indices (2009) (2)
Instrument precision and biological variability determine the number of patients required for rheological studies (2016) (2)
The core outcome measures in effectiveness trials (COMET) initiative: five years on (2015) (2)
QUALITY OF TRIALS Impact of a Systematic Review on Subsequent Clinical Research : The Case of the Prevention of Propofol Injection Pain (2013) (2)
[CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design]. (2005) (2)
Leading with authenticity in challenging times. (2011) (2)
Tobacco growers' knowledge of revenue distribution and foreign prices: implications for health education. (2000) (2)
ISIS and the emergence of large, simple trials (2015) (2)
Prevention in Mental Health A Proactive-Developmental-Ecological Perspective (1989) (2)
Bayesian Approaches to Randomized Trails - Discusion (1994) (2)
Feasibility of establishing a central repository for the individual participant data from research studies (2011) (2)
“Third drug” trial (1984) (2)
Comparing methods of assessing gestational age. (1980) (2)
Patients' preferences and randomised trials (1996) (2)
Treatment Effect Heterogeneity in Clinical Trials: An Evaluation of 13 Large Clinical Trials Using Individual Patient Data. (2014) (2)
Crime and psychopathology (1986) (2)
Can malt whisky be discriminated from blended whisky?: Peer commentaries and riposte: How blind were the volunteers? (1983) (2)
Electronic patient records in general practice. Methods of evaluation of electronic patient records entail dangers. (2001) (2)
Core outcome sets (COS) and the core outcome measures in effectiveness trials (COMET) initiative: patient participation in COS development (2016) (2)
KNEE OSTEOARTHRITIS AND THE RISK OF PREMATURE MORTALITY IN THE COMMUNITY: AN INTERNATIONAL INDIVIDUAL PATIENT LEVEL META-ANALYSIS IN 9889 SUBJECTS (2017) (2)
THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (PART II) (2010) (2)
randomised trials CONSORT statement: extension to cluster (2006) (2)
ENTERIC DISEASE IN SAN FRANCISCO (1977) (2)
Do the left‐handed die young? (2005) (2)
THE ASSOCIATION OF KNEE OSTEOARTHRITIS AND PREMATURE MORTALITY IN THE COMMUNITY: AN INTERNATIONAL INDIVIDUAL PATIENT LEVEL META-ANALYSIS IN SIX PROSPECTIVE COHORTS (2017) (2)
The need for individual trial results in reports of systematic reviews (2017) (2)
Variables and parameters (1999) (1)
Abstract 14595: Effect of Bilateral Internal Mammary Artery on Long-Term Survival: A Meta-analysis Approach (2013) (1)
Need for confidence intervals in reporting clinical trials (1987) (1)
Outcome reporting bias in government-funded RCTs (2005) (1)
Five-year costs from a randomised comparison of bilateral and single internal thoracic artery grafts (2019) (1)
Reporting randomized trials. (2009) (1)
Comparisons within randomised groups (2011) (1)
Adjusted indirect comparison for estimating relative effects of competing healthcare interventions (2016) (1)
Education of children about the sun and skin cancer (1995) (1)
INTERGROWTH-21st: describing optimal fetal growth, newborn size and postnatal growth and development for the improved phenotypic classification of the preterm birth and fetal growth restriction syndromes (2015) (1)
Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial – the development of the DELTA2 guidance (2019) (1)
Re: "Evaluation of two food frequency methods of measuring dietary calcium intake". (1989) (1)
Improving prognosis research (2018) (1)
Randomized Comparison of Single Versus Bilateral Internal Mammary Artery Grafting in 3102 Patients: Effects on Major Cardiovascular Outcomes After Five Years Follow Up (2016) (1)
Reflections on medical journals. (2002) (1)
International Standards for Symphysis-Fundal Height Based on Serial Measurements From the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project (2017) (1)
Suncool: A health education programme for secondary schools (1993) (1)
Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years (2021) (1)
Invited talk: 20 years of Burwalls (2002) (1)
Design-a-Trial (2003) (1)
Left handedness and breast cancer. (1992) (1)
The ORBIT Study: Outcome reporting bias in trials - interviews with trialists who do and do not report all outcomes. (2008) (1)
Characteristics and Dissemination of Phase 1 Trials Approved by a UK Regional Office in 2012 (2017) (1)
Statistics in the medical literature 2 (1995) (1)
Algorithm AS 235: number tally (1988) (1)
Interpreting the number needed to treat. Author's reply (2002) (1)
Correction (1996) (1)
Is there a time factor in renal allograft rejection? (1979) (1)
Reporting Behaviour Change Interventions: the Tidier Interdisciplinary Checklist of the Minimum Recommended Information (2014) (1)
Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients (2020) (1)
Declaration of transparency for each research articlea (2013) (1)
REPORTING OF CONTINUOUS OUTCOME MEASURES IN RANDOMIZED CLINICAL TRIALS: IS THE WHOLE STORY BEING TOLD? (2010) (1)
Statistics notes: Brackets (parentheses) in formulas (2011) (1)
A trial of the comparability of peak expiratory flow meters in schoolchildren. (1977) (1)
Reply to letter to the editor by C. Faggion: reproducibility and reporting guidelines. (2018) (1)
Exploring the role and functionality of trial steering committees (2015) (1)
Mid-arm and chest circumferences at birth as predictors of low birth weight and neonatal mortality (1986) (1)
Kendall, Maurice George † (2005) (1)
Systematic reviews and meta-analysis of prognosis research studies (2019) (1)
CT colonography: Assessment of radiologist peformance with and without computer assisted detection (CAD). (2006) (1)
Re: "quality of reporting of observational longitudinal research". (2005) (1)
An independent validation of QRISK on the THIN database. (2009) (1)
Bilateral versus single internal mammary artery bypass grafts for coronary arterial atherosclerosis (2003) (1)
A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study (2022) (1)
Comment on: Reporting recommendations for tumor marker prognostic studies (REMARK). Authors' reply (2005) (1)
OC06.01: Development of normal fetal brain structures international standards based on ultrasound measurements from the INTERGROWTH‐21st Project (2017) (1)
The STROBE Extensions (2018) (1)
I179 THE INTERGROWTH‐21ST PROJECT: DESIGN, STANDARDISATION AND QUALITY CONTROL STRATEGIES (2012) (1)
Design-a-Trial: A knowledge-based system to support clinical trial designers (1999) (1)
A review of the methodology and reporting of multi-arm, parallel group, randomised clinical trials (2003) (1)
Reporting of clinical prediction model studies in journal and conference abstracts: TRIPOD for Abstracts (2016) (1)
Medical uses of statistics. John C. Bailar, III, and Frederick Mosteller (eds), Nejm books, Waltham mass., 1986. no. of pages: 425. price: £20 (1988) (1)
Which activity index for ulcerative colitis? evaluation of the size and effect of inter_observer variation in clinical, endoscopic and composite indices (2009) (1)
Fetal growth and ethnic variation--authors' reply. (2014) (1)
Development of a combined database for meta‐epidemiological research (2011) (1)
Confidence in confidence intervals. (1991) (1)
Media coverage of tobacco diversification: tradeoffs for community health (2003) (1)
Duty calls: hospitals' responsibility for controlling the tobacco epidemic. (1989) (1)
Job stress and burnout: Research and intervention strategies (1984) (1)
Diet and Disease (1973) (1)
Recognition of Reviewers for the American Journal of Health Promotion (2004) (1)
Marketing adolescent tobacco addiction. (1995) (1)
Interdisciplinary Perspectives on Behavioral Medicine (1988) (1)
Effect of Injury Control Information Integrated into a High School Physics Curriculum (1993) (1)
And Leadership Development for All (2010) (1)
Une nuevo acercamiento a los resúmenes más informativos (1992) (1)
Normas estadisticas para los colaboradores de revistas de medicina (1988) (1)
CHARTS OF FETAL SIZE - REPLY (1994) (1)
Author's response to reviews Title: LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact Authors: (2009) (0)
Fractional polynomials: Correction (1995) (0)
NOTICE: This document contains correspondence generated during peer review and subsequent revisions but before transmittal to production for composition and copyediting: (2019) (0)
Thanks to all those who reviewed for Trials in 2015 (2016) (0)
Stability of Liquid Layers with Blowing (1997) (0)
Tailoring study design to each stage of surgical innovation: the ideal recommendations (2013) (0)
REporting recommendations for tumor MARKer prognostic studies (REMARK). (2005) (0)
The COMET Initiative’s Guide to Selecting Outcomes in Clinical Trials (2021) (0)
Authors’ reply (2009) (0)
CoreOutcomeSet-STAndardsforReporting: TheCOS-STARStatement (2016) (0)
Title : Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania Version : 2 (0)
Recognition of Reviewers of the American Journal of Health Promotion (1994) (0)
Comparison of operative 30 & 90 day mortality between General Surgeons and Cardiothoracic Surgeons in England (2007) (0)
Internet Recruitment Experience for the Oxford Conception Study - a randomised controlled trial (2009) (0)
OP20.09: The intra‐ and inter‐ observer variability in fetal measurements by ultrasound (2011) (0)
The CONSORT Statement: Explanation and Elaboration (2002) (0)
Authors’ reply to Cunningham and Messerli and colleagues (2016) (0)
Observational Versus Randomized: Sliding Toward Nonevidence-Based Medicine. (2017) (0)
Illustration of the timing of prognosis study registration, protocol publication, data sharing, and reporting. (2014) (0)
Interpreting the number needed to treat [4] (multiple letters) (2002) (0)
Thanks to all those who reviewed for Trials in 2014 (2015) (0)
CRISP statistical analysis plan (2014) (0)
Interpretation and discussion (2013) (0)
Pedicled and skeletonized single and bilateral internal mammary artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial (ART). (2019) (0)
Recognition of Reviewers of the American Journal of Health Promotion (1993) (0)
New edicts for letters - Restrictions should not be imposed on post-publication peer review (2003) (0)
Book Review: Statistics for the Clinical Laboratory (1950) (0)
Cutaneous oxygen level in premature and term babies--comparison of different methods of measurement. (1986) (0)
CrIteria for classification of the menstrual cycle and associated serum (2004) (0)
Comprar Beating Heart Coronary Artery Surgery | Matthias Egger | 9780879934736 | Wiley (2009) (0)
Methods: main study (2013) (0)
I029 A PHENOTYPIC CLASSIFICATION FOR THE PRETERM BIRTH SYNDROME: RESULTS FROM THE INTERGROWTH‐21ST PROJECT (2012) (0)
Racial differences inredcell indices (1986) (0)
Introduction to report (2013) (0)
Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review (2018) (0)
Systematic reviews on the prognostic role of biomarkers in heart failure (2018) (0)
Bayesian stopping rules for trials. Authors' reply (2002) (0)
Confidence intervals in Clinical Chemistry. (1994) (0)
Reply to KL Stanhope and PJ Havel. (2016) (0)
Inappropriate use of confidence intervals. (1987) (0)
BALLETS study protocol, version 13.0, March 2010 (2013) (0)
Is longevity inherited? (1982) (0)
CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Simplified Chinese Version). (2017) (0)
Response to Katz and Kattan (2006) (0)
Evidence-Based Medicine EBM NOTEBOOK Down with odds ratios ! (2011) (0)
Correction: Odds ratio should be avoided when events are common (British Medical Journal (1998) 7 November (1318)) (1998) (0)
Differing methods of assessing immunohistochemical staining for oestrogen receptors: a statistical approach. (1997) (0)
Overinterpretation and misreporting of prognostic factor and biomarker studies in medical oncology. (2017) (0)
Recognition of Reviewers for the American Journal of Health Promotion (2014) (0)
VII?Interpreting results (2016) (0)
Reflections on medical journals [5] (multiple letters) (2002) (0)
Updating standards for reporting diagnostic accuracy: the development of STARD 2015 (2016) (0)
Medical Statistics: A Commonsense Approach (1991) (0)
Intrauterines fetales Wachstum – Definition international gültiger Standards für das fetale Wachstum (2015) (0)
Author's response to reviews Title: Design, Analysis, and Presentation of Crossover Trials Authors: (2009) (0)
Cigarette Sales to Minors Through Vending Machines-Reply (1989) (0)
ALTMAN right ROC curves and confidence intervals : getting them (2000) (0)
Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization (2019) (0)
Response to “How to judge a tumor marker” Katz and Kattan (2005) (0)
adherence to methodological or reporting quality (2017) (0)
Tobacco and kids: using creative epidemiology to move an audience (1992) (0)
Reply: (2011) (0)
Part IV : Statistical methods and computer software (2001) (0)
' s response to reviews Title : Clinical efficacy and prognostic indicators for lower limb pedalling exercise early after stroke : A pilot randomised controlled trial (2011) (0)
A Message from the Associate Editors (2000) (0)
Reporting of Randomised Trials Reporting of Randomised Trials (0)
I286 DEVELOPING A NEW, INTERNATIONAL EQUATION TO ESTIMATE GESTATIONAL AGE BY EARLY ULTRASOUND (2012) (0)
' s report Title : External validation of a Cox prognostic model : principles and methods Version : 2 (2013) (0)
Authors' reply (1996) (0)
dults ’ Approval and Adolescents ’ Alcohol Use (2004) (0)
JAMA Peer Reviewers in 2004 (2016) (0)
CONSORT for Noninferiority and Equivalence Trials (2014) (0)
What can available randomised controlled trials evaluating monitoring strategies tell us about the design and analysis of future trials? (2011) (0)
BMJ statistical errors [letter] (2004) (0)
National evaluation of the enforcing underage drinking laws program: design and baseline data (2000) (0)
Do declarative titles affect readers’ perceptions of research findings? A randomized trial (2016) (0)
' s report Title : External validation of a Cox prognostic model : principles and methods Version : 2 (2013) (0)
Recognition of the Reviewers of the American Journal of Health Promotion (1988) (0)
CONSORT for Cluster Randomized Trials (2014) (0)
Missing covariate data in the construction of prognostic models: A review of current approaches (2003) (0)
Polyp classification error at endoluminal CT colonography: characteristics of polyps viewed but incorrectly dismissed by radiologists. (2014) (0)
STRATOS News vol. 1 (2018) (0)
Critical Methodology with Doug Altman (2009) (0)
The Development of the CONSORT Explanatory Document (2005) (0)
Bayesian stopping rules for trials (2002) (0)
Medical uses of statistics. 2nd edn., John C. Bailar III and Frederick Mosteller (eds.), NEJM Books, Boston, 1992. No. of pages: xxvii + 449. Price: $39.95. ISBN: 0‐910133‐26‐0 (1994) (0)
cancer: review of methods and reporting Systematic reviews of diagnostic tests in (2006) (0)
Results of randomised trials – relative or absolute effect measures? (2017) (0)
for IgG , IgA , IgM . nephelometry : reference ranges children measured by laser concentrations in preschool Serum immunoglobulin (0)
Outcome reporting bias in trials (2009) (0)
' s response to reviews Title : Xenon for the prevention of postoperative delirium in cardiac surgery : study protocol for a randomized controlled clinical trial (2015) (0)
Re: Testing for blinding is the only way to determine whether a trial is blind (2018) (0)
Draft of 9.83 Printed 19.11.86 EVALUATING A SBRTES DE eLJNICAT, TRIALS DF THE SAME TREATMEUT (2015) (0)
CRISP study centres and principal investigators (2014) (0)
Towards best reporting practices for clinical pharmacology trials (2013) (0)
Systematic review of methods for specifying a target difference (2014) (0)
Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction (2016) (0)
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330]. (2020) (0)
Comment on: Visualizing Length of Survival in Time-to-Event Studies : A Complement to Kaplan-Meier Plots. Authors' reply (2008) (0)
Introducing the adaptive designs CONSORT extension (ACE) statement to improve reporting of randomised trials that use an adaptive design (2019) (0)
DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial (2018) (0)
JAMA Peer Reviewers for 2003 (2017) (0)
P42 Blinding and exclusions after randomization in controlled trials (1995) (0)
Points: Inappropriate use of confidence intervals (1987) (0)
Douglas Graham Altman, 1948–2018 (2018) (0)
More than half of the TRIPOD items are inadequately reported in prediction modelling studies (2016) (0)
VI?Presentation of results (2016) (0)
Fatty acid accretion in human fetal and neonatal times. (1982) (0)
Tobacco Promotion andSusceptibility toTobacco Useamong Adolescents Aged12through 17Yearsina Nationally Representative Sample (1996) (0)
2 DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial (2018) (0)
Outcome reporting bias in government-funded RCTs - Reply (2005) (0)
Systematic review of pharmacological treatment of obsessive compulsive disorder (OCD) in adults (2004) (0)
Absence of evidence and the importance of confidence intervals (2018) (0)
Everything you always wanted to know about systematic reviews but never wanted to ask (2000) (0)
Octreotide infusion versus injection sclerotherapy. (1993) (0)
Short reviews of new editions (1990) (0)
important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and countries. (2018) (0)
Reply: An Incomplete Story. (2018) (0)
Journeying through the development of a consensus-driven adaptive designs reporting guidance (2017) (0)
Overinterpretation and misreporting of prognostic factor studies in medical oncology (2016) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Title : Intravenous magnesium prevents atrial fibrillation after coronary artery bypass grafting : a meta-analysis of 7 double-blind , placebo-controlled , randomized clinical trials (2012) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
RESTRICTED RANDOMIZATION IN RANDOMIZED CONTROLLED TRIALS. AUTHORS' REPLY (1995) (0)
How can monitoring impact on patient outcomes (2018) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Author's response to reviews Title: Dealing with Heterogeneity of Treatment Effects: Is the Literature Up to the Challenge? A Systematic Review Authors: (2009) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Allocation concealment terminology: origins and evidence (2018) (0)
Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
Surveys of triallists’ current practice (2014) (0)
Tobacco use (1991) (0)
Book reviewPresentation of clinical data: By Bert Spilker and John Schoenfelder, Raven Press, New York, 1990, 553 pages, $80 (1991) (0)
Randomised trials useful to find best methods of enhancing clinical practice (1999) (0)
Fostering a border understanding of health and health care: The health psychology model (1990) (0)
Survey from sent to UK- and Ireland-based triallists (2014) (0)
Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials - Comment (2005) (0)
Measurement error. (1996) (0)
Reporting power calculations (2017) (0)
[Randomization and comparison of final quality in clinical studies]. (2005) (0)
CHARTS OF FETAL SIZE. AUTHORS' REPLY (1994) (0)
Results: main study (2013) (0)
Thanks to all those who reviewed for in 2014. (2015) (0)
Guidance on specifying the target difference in a randomised controlled trial sample size calculation (2014) (0)
Envisioning information. Edward R. Tufte, Graphics press, Cheshire, Connecticut, 1990. no. of pages: 126. price: £30/$48. ISBN: 0‐961‐39211‐8 (1993) (0)
Epidemiology of recent randomised controlled trials (2003) (0)
CONSORT PRO 2012: translating guidance to practice (2012) (0)
Recognition of Reviewers for the American Journal of Health Promotion (1996) (0)
PEAK-FLOW METER AND PEAK-FLOW GAUGE (1974) (0)
DELTA (Difference ELicitation in TriAls)2 advice and recommendations for researchers and funder representatives – output from literature reviews, Delphi study, workshop and stakeholder engagement (2019) (0)
17 – La red EQUATOR: facilitando la comunicación transparente y precisa de la investigación sanitaria* (2010) (0)
Group Multiple Significance Tests : The Bonferroni Method Author ( s ) : (2008) (0)
Predicting rural health care utilization with archival data (1982) (0)
Challenges in Evaluating Decision Support Systems with Complex Outputs : Lessons from Design-aTrial (2001) (0)
Design fl aws in EuroSCORE II (2013) (0)
Synergies between public health and management. (2006) (0)
Presentation of clinical data (1991) (0)
Effect on Integration Injruy Control Information into A High School Physics Course (1996) (0)
CHAPTER 5 Ambiguities and Confusions Between Reporting and Conduct (2014) (0)
Risk heterogeneity in clinical trials: An evaluation of 25 large clinical trials using individual patient data (2014) (0)
The CONSORT statement: Explanation and elaboration - In response (2002) (0)
Conventional approach to a randomised controlled trial sample size calculation (2019) (0)
' s response to reviews Title : Effects of Anma-massage therapy ( Japanese massage ) for gynecological cancer survivors : study protocol for a randomized controlled trial (2013) (0)
The CONSORT statement: Explanation and elaboration. Authors' reply (2002) (0)
Statistics notes: Authors' reply (1994) (0)
An assessment of the design and dissemination of phase I clinical trials: where can we improve? (2017) (0)
Medical Laboratory Statistics (1982) (0)
Adherence of trials of operative intervention to the consort statement for non-pharmacological treatments: A comparative study (2012) (0)
New edicts for letters (2003) (0)
BALLETS study analysis (2013) (0)
Elements to consider including in registration, protocols, reporting, and data sharing a . (2014) (0)
analysis . computerised interactive image bowel disease using Quantitation in inflammatory (0)
Ebook: Systematic reviews in health care (2013) (0)
Chapter 15 Sequencing Issues in Health Behavior Program Development (2001) (0)
Comment on: Qquality of reporting of observational longitudinal research. Authors' reply (2005) (0)
SPIRIT promotes protocol sharing. (2018) (0)
Reflections on medical journals. Author's reply (2002) (0)
P20.09: The probability of cephalic presentation across pregnancy in the INTERGROWTH‐21st fetal growth longitudinal study (2017) (0)
P2-12-03: A Prospective Study of the Prognostic Implications of Being a BRCA1 Carrier for Young Onset Breast Cancer Patients. (2011) (0)
An Ethic for Health Promotion: Rethinking the Sources of Human Well-Being Professor David Buchanan Oxford University Press, New York, 2000 232 pp. ISBN 019 513057X (hb) (2002) (0)
A Primer on Tobacco Production: Implications for Health Promotion Practice (2000) (0)
Factors affecting the impact of covariate adjustment for binary outcomes in randomised clinical trials (RCTS): a simulation study (2015) (0)
extending the CONSORT statement in Clinical Trials of Acupuncture (STRICTA): Revised STandards for Reporting Interventions (2010) (0)
Youth, Tobacca, and the Social Context (1998) (0)
An Examination of Top Leaders' Self-Talk, Effectiveness, and Job Strain (2012) (0)
BALLETS study: summary of ethics and substantial amendment approval (2013) (0)
Anthropometric Characterization of Impaired Fetal Growth (2015) (0)
Trial Steering Committee and Data Monitoring and Safety Committee members (2014) (0)
' s response to reviews Title : The effectiveness of VIPP-V parenting training for parents of young children with a visual or visual-and-intellectual disability : Study protocol of a multicenter randomized controlled trial (2015) (0)
The nutrient intake of Kent schoolchildren. (1972) (0)
False Reassurance Based on Non-Significant Results (2017) (0)
The need for standardised outcomes in cancer clinical trials: a report of cancer core outcome sets (2015) (0)
Pedicled and skeletonized single and bilateral internal mammary artery grafts 3 and the incidence of sternal wound complications : Insights from the Arterial 4 Revascularization (2017) (0)
CRISP case report forms and database validation (2014) (0)
QRISK2-2011 predicted cardiovascular disease in adult general practice patients (2012) (0)
NIHR Liver/Renal Biomarker Programme Final Report: Evaluating the benefits for patients and the NHS of new and existing biological fluid biomarkers in liver and renal disease (2017) (0)
Clinical experimentation in obstetrics (1988) (0)
I379 EARLY FETAL GROWTH ACROSS DIFFERENT GEOGRAPHICAL REGIONS: ARE FETUSES SIMILAR IN THE 1ST TRIMESTER? (2012) (0)
Mixed-up confusion. Response to 'Freewheelin’ scientists: citing Bob Dylan in the biomedical literature', BMJ 2015;351:h6505 (2016) (0)
Research Methods & Reporting: Taking healthcare interventions from trial to practice (2010) (0)
Recognition of Reviewers of the American Journal of Health Promotion (1991) (0)
CTC: Assessment of observer performance with and without computer-assisted detection. (2006) (0)
ON- VS OFF CABG: EFFECTS ON POSTOPERATIVE LACTATE, BASE EXCESS AND PH OVER THE FIRST 24 HOURS IN INTENSIVE CARE (2014) (0)
An Interview with Jeffrey Koplan, MD, MPH, Director, Centers for Disease Control and Prevention (2000) (0)
Letters to the Editor (0)
Moderate Alcohol Intake and Cardiometabolic Risk in Adults With Type 2 Diabetes (2016) (0)
Book Reviews: A New Feature (1989) (0)
Authors's reply (1994) (0)
Looking Ahead: Education and Training in Behavioral Medicine (1988) (0)
Reporting Randomized Trials. Authors' reply (2009) (0)
University of Birmingham Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? (2017) (0)
Statistics in Practice: Statistics in Question and Statistics and Ethics in Medical Research. (1983) (0)
CLAIMS FOR GLANDULAR SUPPLEMENTS STILL UNSUBSTANTIATED (2010) (0)
Why does medical research sometimes get it so wrong ? (2011) (0)
Medical Journals, Statistical Articles in (2005) (0)
Correction: Odds ratios should be avoided when events are common (British Medical Journal (1998) 317 (1318)) (1998) (0)
A randomised phase II study of interferon alpha alone or in combination with thalidomide in metastatic renal cancer. (2004) (0)
QRISK evaluation: Authors response (2018) (0)
Characteristics of Available Reporting Guidelines (2014) (0)
Restricted Randomization in Randomized Controlled Trials-Reply (1995) (0)
JAMA Peer Reviewers in 2018. (2019) (0)
Impact of measurement error and sample size on the performance of multivariable risk prediction models: a simulation study (2017) (0)
Authors’ reply to Bird (2012) (0)
Medical Statistics on Microcomputers (1991) (0)
Design-a-Trial: a knowledge-based aid for authors of clinical trial protocols. (1999) (0)
Basic statics for laboratories. A primer forlaboratory workers. William D. Kelley, Thomas A. Ratiff Jr. and Charles Nenadic, New York, van Nostrand Reinhold, 1992. No. of pages: ix + 175. price: £32.50. ISBN: 0‐442‐00456‐7 (1993) (0)
Urinary abnormalities innon-gonococcal urethritis (1981) (0)
Bayesian stopping rules for trials - Reply (2002) (0)
The effect of computer-aided detection markers on visual search and reader performance in CT colonography. (2014) (0)
The benefits and harms of breast cancer screening Reply (2013) (0)
u Acceptance Address: Good Reporting— An Essential Component of Good Science CSE Award for Meritorious Achievement (2007) (0)
Model assumptions and limitations (2017) (0)
University of Birmingham Meta-analysis, simpson's paradox and the number needed to treat (2002) (0)
Informed consent. (1993) (0)
Systematic Reviews (1999) (0)

This paper list is powered by the following services:

Other Resources About Doug Altman

en.wikipedia.org

What Schools Are Affiliated With Doug Altman?

Doug Altman is affiliated with the following schools:

Doug Altman's Academic­Influence.com Rankings

Why Is Doug Altman Influential?

Doug Altman's Published Works

Published Works

Other Resources About Doug Altman

What Schools Are Affiliated With Doug Altman?

Image Attributions

Doug Altman's AcademicInfluence.com Rankings